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ABSTRACT
Tshwane is one o f three metropolitan municipalities in Gauteng Province and a cross 
border district with North West Province. Tshwane has a complex Drug Supply 
Management system. Gauteng Provincial Authority (GPA), North West Provincial 
Authority (NWPA) and City o f Tshwane Metropolitan Municipality (CTMM) play 
significant roles. This has resulted in duplication o f duties and inefficient use o f 
resources.
The aim of the study was to describe the current Drug Supply Management System in 
Tshwane, identify any weaknesses plus the factors responsible for the observed 
weaknesses and formulate recommendations for improvement.
It was both a retrospective and prospective observational study using indicators and 
structured questionnaires based on those developed by World Health Organisation and 
Health Systems Trust. Prospective data was collected between September and 
December 2002 while retrospective data covered the period from July 2001 to the day 
of data collection (approximately one year).
Major Observations
Based on the WHO drug use indicators, Drug Supply Management in Tshwane was 
below performance targets.
• The facilities and conditions for storage for medicines were inadequate.
• The service level o f the pharmacies/sub-depots to primary health care facilities 
was low.
• Availability o f  drugs was low and key drugs were frequently out o f stock.
• Stock control procedures were inadequate.
• Availability of, and adherence to, standard operating procedures was inadequate.
• The methods used to quantify drug utilization were inadequate.
• The personnel for Drug Supply Management were inadequate in number and 
training. Their skills were not appropriately deployed.
• The use o f generic names was very low.
• The use o f  antibiotics was high.
• There was inadequate information flow about budget and budgeting processes.
The cadre, training and method o f deployment o f the staff in charge plus availability 
o f standard operating procedures had not had a significant impact on the status of 
Drug Supply Management in Tshwane (p > 0.05).
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Clinics supplied by independent sub-depots were associated with more availability 
and less stock out incidences o f  key drugs, as compared to those supplied by hospital 
pharmacies (p = 0.0024). Use o f a formal method o f quantification o f drug 
requirements was associated with more availability and less stock out incidences of 
key drugs, as compared to relying only on working experience to quantify drug 
requirements (p = 0.01381).
Major Recommendations
The following recommendations were made to improve Drug Supply Management in 
Tshwane:
• Ensure that each clinic has a person properly trained in and dedicated to Drug 
Supply Management who should be effectively supervised.
• Ensure that each clinic has and uses well-developed standard operating 
procedures.
• Formal quantification methods should be developed, standardized and used in all 
areas o f management.
• Primary Health Care Facilities should be supplied from an independent Sub-depot 
as opposed to a hospital pharmacy.
• Strengthen and increase accountability for drugs up to dispensing level.
• Improve information flow about budget and budgeting process and involve clinic 
staff in budget control.
Some o f these recommendations were presented to and accepted by the Tshwane Joint 
Task Team on Drug Supply Management, the Health District Joint Management 
Team and the Gauteng Health District Forum in 2003.
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GLOSSARY
The following terms shall take the following meaning in this study. These are adapted 
from world Health Organisation (WHO) '.
a. Generic name shall be the name that appears in the Standard Treatment 
Guidelines and Essential Drug List for South Africa.
b. Consultation time shall be duration from beginning to end for individual 
consultations. If patients are seen one by one in a consultation room, this will 
mean measuring the time between entering and leaving the consultation room.
xv
c. Dispensing time shall be duration from beginning to the end o f patient interaction 
with the dispenser. It shall refer to the time from when the patient approaches the 
dispensary window to receive medicine to when he or she leaves the window. The 
waiting time before the patient hands the prescription in to be filled is not 
counted. If  medicines are dispensed by the Prescriber in the consultation room, the 
time spent in the room shall be taken as the total consultation and dispensing time.
d. Drugs Dispensed, when the drug dispensed is the one prescribed but in quantities 
different from the prescription due to low stocks or an institutional policy limit, 
shall be counted as if it has been dispensed as indicated, with a special note on the 
record form.
e. Drugs Adequately Labelled shall be those drug packages containing at least 
patient name, drug name and when the drug should be taken.
f. Adequate Patient’s knowledge about medication shall be when the patient can 
demonstrate knowledge o f when and in what quantity each drug actually 
dispensed should be taken. Failure to know either o f these two points about any of 
the drugs dispensed shall be scored as inadequate patient knowledge. Terms used 
to state when drugs should be taken shall relate to actual time intervals. These 
shall be evaluated against data written on drug package or prescription form.
g. Availability of Key Drugs. For the purpose o f this indicator, brand name and 
generic drugs are chemically equivalent. The quantity in stock shall not be 
considered. Even if only one bottle or a few tablets are available, the drug should 
be recorded as being in stock. Each formulation, strength and pack size was 
considered as a different item even if they contained the same active ingredient.
h. Antibiotics. For the purpose o f assessing the percentage o f encounters with an 
antibiotic prescribed, the following classes o f antimicrobial agents, derived from 
the WHO Model List o f Essential Drugs, were included in the definition o f an 
antibiotic
>  Penicillins
>  Other antibacterials
>  Anti-infective dermatological drugs
>  Anti-infective ophthamological agents
>  Anti-diarrhoeal drugs with streptomycin, neomycin, nifuraxazide 
or combinations
xvi
For clarity, Metronidazole and co-trimoxazole were considered antibiotics but 
nystatin was not.
i. Health Facility is used to collectively mean both a Community Health Centre and 
a clinic. Primary Health Care Facility and Facility carry the same meaning.
j. Sub-depot means a drug outlet used for distribution o f drugs to public health 
facilities within a District or Region within a province. Depot is the equivalent 
term at the provincial level.
k. Independent Sub-depot is one neither operationally nor administratively 
attached to another health facility. In this respect, a hospital pharmacy that 
supplies primary health care facilities is a sub-depot attached to a hospital.
l. Receiving procedures are considered adequate when received stock are off­
loaded in a secure cage where it is quarantined and checked against the order, 
invoice and delivery note before placing it in the main store. The delivery note 
should be in duplicate and both parties must retain a signed copy. Any 
discrepancies should be formally reported within a stipulated period.
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1. INTRODUCTION
1.1.Background Information
Medicines are the second highest expense after staff costs in a country's health care 
system.2 Availability o f medicines has been shown to enhance utilisation o f health 
facilities, the reputation o f health professionals and the entire health care system in 
general.3
In many developing countries, a high percentage o f medicine losses occur in the State 
procurement, storage, distribution, and utilisation system. The World Bank estimated 
that, in Africa, the patient receives only 12 cents out o f every dollar spent by the 
Government on medicines 4. Table 1.1 below lists the inefficiencies associated with this 
loss. Inefficiency is the major contributor to these losses.
Table 1.1 Inefficiency and Waste in Supply of Drugs in Africa*
PRACTICE WHERE LOSS OCCURS % LOSS
1 Inadequate buying practices 10%
2 Quantification problems 14%
3 Inefficient procurement 27%
4 Inefficient distribution 19%
5 Irrational prescribing 15%
6 Patient non-compliance 3%
Total loss 88%
* Adopted from World Bank Report: Better Health in Africa, 19944.
All these losses that occur in the supply chain add up to 88% o f the original budget 
allocated 4.
In South Africa, 80% o f the population are dependent on the Government to provide for 
their health care needs, mainly through the Primary Health Care (PHC) Facilities. It is
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thus crucial for the Government to ensure efficient availability o f essential medicines for 
its citizens at the facilities. Currently in South Africa, both Provincial Governments and 
Local Authorities operate Primary Health Care clinics. It is Government policy that, 
although Primary Healthcare shall remain a responsibility o f the Provincial Government, 
implementation should be integrated and devolved to the Local Authorities. The process 
o f integration and devolution must be informed by an accurate evaluation o f the current 
status o f the facilities and systems operating under the different authorities5.
Tshwane is one o f the metropolitan municipalities in Gauteng Province and a cross border 
district with North West Province (Figure 1.1, page 3). It incorporates parts o f Odi and 
Moretele districts from North West Province and former City o f Pretoria areas. As a 
result, Tshwane has a complex drug supply system with Gauteng Provincial Authority 
(GPA), North West Provincial Authority (NWPA) and City o f Tshwane Metropolitan 
Municipality (CTMM) playing significant roles. This has resulted in duplication o f duties, 
inefficient use o f resources, weaknesses in the Drug Supply Management System6, and 
over-expenditure on drugs7.
In Tshwane, two processes o f integration are taking place, namely: -
• Integration o f some clinics formerly under Moretele and Odi districts o f North West 
Province into Tshwane, Gauteng Province.
• Devolving implementation o f all Primary Health Care activities at all clinics in 
Tshwane to the Local Authority, including those currently operated by the Gauteng 
Provincial Government.
Attempts have been made to assess various aspects o f Primary Health Care services in 
Tshwane to inform the integration process in Tshwane. Stafford el al carried out an audit 
on drug utilisation in Tshwane8. This audit focused on control o f drugs and expenditure. 
Its limitations included a limited sample (17 clinics) and standard drug use indicators 
were not used. It was carried out by the staff o f the Department o f Health in Tshwane who
2
Figure 1.1 Map showing Municipalities of Gauteng and Tshwane as a Cross-border District 3
are the implemented o f Drug Supply Management (DSM), against a background o f 
counter accusations between Provincial and Local Authority stalf. This introduced the 
potential o f bias to underestimate the deficiencies for fear o f being blamed for observed 
deficiencies. Despite these limitations, the audit pointed out a number o f weaknesses in 
Drug Supply Management in Tshwane.
Another survey o f the Information Infrastructure at all the Primary Health Care clinics 
and their respective management structures in Tshwane observed that no proper 
pharmaceutical stock management systems existed 9. This survey looked generally at all 
services with a special focus to Information Technology and communication facilities but 
did not give enough attention to Drug Supply Management facilities. It observed that no 
proper pharmaceutical stock management systems exist and different ordering, dispensing 
and stock control systems were in use which was likely to impact negatively on the future 
consolidation o f pharmaceutical systems 9.
Due to persistent problems in Drug Supply Management in Tshwane, the Joint District 
Health Management Committee requested Health Systems Trust to assist in improving 
Drug Supply Management, among other things. A preliminary report produced by the 
Health Systems Trust facilitator in 2001 noted the following problems10: -
• Duplication o f drug supply systems.
• Inadequate numbers, skills and deployment o f staff responsible for Drug Supply 
Management.
• Inadequate controls for drugs at different levels o f supply and use.
• Over expenditure on medicines.
According to the report o f the analysis o f Phase 1 o f the Integrated Development Plan o f 
City o f Tshwane Metropolitan Municipality7, the actual drug expenditure was projected to 
be R8 million compared to a budget o f R4.12 million. This sparked off a dispute between 
the Departments o f Health o f the City o f Tshwane Metropolitan Municipality (CTMM)
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and the Gauteng Provincial Authority (GPA). Officials from the two authorities could not 
agree on whether the primary problem was over-expenditure or under-budgeting. A task 
team including the Health Systems Trust facilitator was set up to look into the alleged 
over-expenditure. The task team rejected the report compiled in 2000 by Stafford et al 
because o f its limitations, namely inadequate sample size, methodology, and possible 
bias. They recommended that an independent person be engaged to conduct a situation 
analysis on Drug Supply Management in Tshwane to confirm the status, identify any 
possible weaknesses and make recommendation for improvement. This current research 
report is designed to inform the above process.
1.2.The Drug Management Cycle*
Drug management involves four basic functions as shown in Figure 1.2 below, namely: 
selection, procurement, distribution and use11.
Figure 1.2 The Drug Management Cycle
* Adopted from Managing Drug Supply, Second Edition, by Quick JD et al MSH and WHO-DAP, p. 15, 
West Hartford, Connecticut, USA: Kumarian Press".
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Selection involves reviewing the prevalent health problems, identifying treatments of 
choice, choosing individual drugs and dosage forms, and deciding which drugs will be 
available at each level o f health care. This has already been done through the Essential 
Drug List and the Standard Treatment Guidelines.
Procurement includes quantifying drug requirements, selecting procurement methods, 
managing tenders, establishing contract terms, assuring drug quality, and ensuring 
adherence to contact terms. The clinics only participate in quantifying drug requirement. 
The others are done either at the National, Provincial or Municipality level.
Distribution includes stock control, stores management, delivery to drug depots, sub­
depots and health facilities. This is done by the departments o f health at the National, 
Provincial or Municipality level, but sometimes, it is outsourced. The clinic health 
workers, however, are supposed to control stock and manage stores at the facility.
Use includes diagnosis, prescribing, dispensing and proper consumption by the patient.
Each function builds on the previous one and leads logically to the next. Costs rise, 
shortages become common, and patients suffer when the separate tasks are performed not 
as part o f  a system but independently and disjointedly. The management support systems 
at the centre o f the cycle, which include physical facilities, organisation, financing, 
information management, and human resource management, hold the drug management 
cycle together. The entire cycle rests on a policy and framework that establishes and 
supports the public commitment to essential drug supply.
To ensure an effective Drug Supply Management, all aspects o f the drug management 
cycle must be regularly assessed individually and collectively, using objective indicators 
and specific performance targets. World Health Organisation (WHO) has come up with 
such Drug Supply Management Indicators and Performance Targets. These will be 
discussed in more detail while discussing the methodology.
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In many parts o f the world, studies have been conducted using WHO Drug Supply 
Management Indicators. Table 1.2 (page 8) is a review o f the indicator values, which have 
been observed in the countries indicated . Indicators were used to mcrease awareness 
among prescribers in Malawi13 and Bangladesh14; to identify priorities for action (e.g., 
polypharmacy in Indonesia14 and Nigeria15, overuse o f injections in Uganda16, Sudan17 
and Nigeria15, and low percentage o f patients who understood the dosage schedule in 
Malawi ); and to quantify the impact o f interventions in Yemen , Uganda , Sudan , 
and Zimbabwe19.
In Northwest Ethiopia, drug use indicators for health centres and health stations were 
found to be similar despite differences in manpower20. In Nigeria, an indicator study was 
used to describe the current drug use practices at a general hospital and gather baseline 
data for use in designing an intervention to improve the drug use profile .
In a randomised controlled indicator study in Zimbabwe, while training o f health workers 
throughout the country in drug management (including stock management and rational 
drug use) resulted significant improvements in a variety o f drug supply management 
indicators; these achievements could not be sustained until a further intervention of 
support supervision was introduced .
In Kampong Thom Province o f Cambodia an indicator study was used to obtain baseline 
information for the design o f a strategy to address irrational prescribing practices . In 
Niger, an indicator study that was used to evaluate an essential drugs and costs recovery 
programme, increasing prescription costs were attributed to overuse o f injections, 
polypharmacy and poor compliance with standard treatment guidelines24. In addition, 
training courses seemed to have a limited impact on prescribing patterns for nurses.
An indicator study was used to assess the proportion o f primary care physician offices in 
four cities in USA25 meeting vaccine storage guidelines, identify factors associated with
1.3.Literature Survey
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Table 1.2 A Review of Drug Use Indicators
Country BAN CAM ECU GHA GUA IND MAL MOZ NEP NIG SUD SWA TAN UGA UGA YEM ZIM
Date (mm/yy) 08/91 10/92 10/92 07/91 06/91 05/92 02/92 05/91 02/92 09/90 03/94 03/88 07/91
No o f facilities 20 20 19 20 10 20 72 26 20 20 37 20 20 42 127 19 56
Reference 14 11 29 11 11 14 13 11 28 15 17 11 27 16 26 18 19
INDICATORS
Av. Drugs/Patient 1.4 3.0 1.3 4.3 1.4 3.3 1.8 2.2 2.1 3.8 1.4 3.0 2.2 1.9 2.4 1.5 1.3
% Patients given ABs 31% 51% 27% 47% 27% 43% 34% 43% 43% 48% 63% 54% 39% 56% 53% 46% 29%
%Patients given INJTs 0.2% 41% 17% 56% 13% 17% 19% 18% 5% 37% 36% 38% 29% 48% 36% 25% 11%
%Drugs by Generic name 58% 37% 59% 72% 59% 99% 44% 58% 63% 63% 82% 86% 94%
% drugs on the EDL 86% 88%
Av. consultation (Min) 3.0 2.3 3.7 3.5 6.3 6.1 3.0
Av. Dispensing time (Sec) 86.1 12.5 77.8
%Patients know dosing 63% 82% 27% 82% 56% 81% 87% 75% 29%
%  drugs actually dispensed 83% 70%
%  o f tracer drugs in stock 38% 67% 87% 90% 62% 92% 72%
KEY: BAN = Bangladesh, CAM = Cameroon, ECU = Ecuador, GHA = Ghana, GUA = Guatema a, IND = Indonesia, MAL = Ma awi, MOZ = Mozambique, NEP = Nepal,
NIG = Nigeria, SUD = Sudan, SWA = Swaziland, TAN = Tanzania, UGA = Uganda, YEM = Yemen, ZIM = Zimbabwe,
ABs = Antibiotics, Av. = Average, INJTs = Injectables, Min = Minutes, Sec = Seconds.
Adopted from Rational Drug Use in Rural Health Units of Uganda: Effect of National Standard Treatment Guidelines on Rational Drug Use, Kafuko et at, p.3, Marianum Press, 199617; 
Managing Drug Supply, Second Edition, MSH and WHO-DAP, p.437, Kumarian Press" , and How to investigate drug use in health facilities: Selected drug use indicators, WHO/DAP/93.f.
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low compliance, and evaluate whether a quality improvement activity improves 
compliance. Adherence to guidelines improved after the intervention, especially with 
respect recording fridge temperature and avoidance o f storage o f vaccine in the fridge 
door.
WHO Drug Supply Management Indicators were the basis o f the guidelines 
developed by Andy Gray and David McCoy, on behalf o f Health Systems Trust, for 
performing a situation analysis o f Drug Supply Management Systems in South 
Africa30,31. These guidelines and indicators have also been validated and used to 
conduct studies in South Africa32'34.
From the above literature review it can be noted that Drug Supply Management 
Indicators are very versatile and can be used to generate useful information about the 
entire drug management cycle under a variety o f settings.
1.4.0bjectives
The specific objectives o f this study are: -
• to describe the status o f the current Drug Supply Management system(s) in 
Tshwane using the WHO and Health Systems Trust Drug Supply Management 
indicators,
• to measure the gap between the currents status and target indicators,
• to identify the factors responsible for any observed weaknesses, and
• to formulate recommendations for the improvement o f Drug Supply 
Management systems.
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The report is organised in five chapters. The first chapter is dedicated to the 
description o f the study subject, the objectives o f  the study, justification o f the study 
and literature review.
The second chapter covers a description o f the methodology, sampling, data 
management, the hypotheses tested and the limitations o f the study.
Results o f  the study are reported in the third chapter. It begins with a description o f 
characteristics o f the sample evaluated. This is followed by a report on the status o f 
Drug Supply Management and the results o f the assessment o f  the impact o f various 
factors as laid out in the hypotheses.
The fourth chapter covers discussion o f results. Results are compared with standard 
performance targets to identify gaps, if any. The reasons for the gaps are analysed 
using the null hypotheses.
The fifth chapter includes the recommendations and conclusion. A list o f references 
comes after the fifth chapter. All bulky tables o f  results and the tools used in the study 
are included in the appendices.
1.5.Structure of the Report
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2. METHODOLOGY
2.1.Introduction to the Indicator-Based Methodology
Given the lack o f consensus on the extent o f the problems associated with Drug 
Supply Management in Tshwane and in the absence o f independent and reliable 
information specific to the area, a new situation analysis using the WHO1 and Health 
Systems Trust ’ indicator based tools was needed.
The International Network for Rational Use o f Drugs (INRUD) and WHO-Drug 
Action Programme have come up with Drug Supply Management Indicators, which 
can be adopted in a study o f drug use1’1 . An indicator is defined as a criterion used to 
measure changes, directly or indirectly, and to assess the extent to which the targets 
and objectives o f a programme are being attained. Indicators should meet the criteria 
o f clarity, usefulness, measurability, reliability, validity and be acceptable to key 
stakeholders. These indicators measure key aspects o f  the Drug Management Cycle. 
They are reliable, highly standardised and are accompanied by a standard 
methodology to collect data. Data collected through the indicators can be compared 
with studies in other facilities, countries, or performance targets.
The purpose o f each indicator, which was used in this study, is outlined in Appendix 
B1 (page 81). The various sub-groups o f the indicators cover the different aspects of 
the drug management cycle 
2.2.Study Design
Taking into consideration the background to the study, the study objectives and the 
resource constraints, a basic cross-sectional study design was used. The guidelines for 
basic parameters o f  the different types o f drug use studies as recommended by WHO1 
are outline in Table 2.1 (page 12).
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Table 2.1 Basic parameters of Different Types of Drug Use Studies4
Cross-sectional
(basic)
Cross-sectional
(comparative)
Supervision
Assess impact of 
intervention
Objectives of 
the indicators 
study
To measure 
drug use 
indicators in a 
representative 
group of 
facilities
To compare between 
individual facilities or 
prescibers, or between 
groups
To identify 
whether a facility 
is above or below 
a set norm of 
practice
To assess the impact 
o f an intervention in 
an intervention and 
control group
Number of
facilities
included
1
20
At least 10 in each group, 
20for more reliable 
comparisons: for individual 
comparisons, each facility 
is considered separately
Each facility
sampled
separately
At least 20 per group
Number of 
prescribing 
encounters per 
facility
30
30 for comparing groups; 
100 for individual facilities 
or prescribers
About 15 for 
identifying 
outliers with poor 
practices
At least 30, but 
depends on the need 
for precision
Type of
prescribing
data
Retrospective or 
prospective
Retrospective or 
prospective
Prospective 
preferred, but 
retrospective 
possible
Retrospective 
preferred, but 
depends on objectives 
and structure of 
intervention
Time frame of
prescribing
data
One year, if 
possible
One year, if possible
One day, or short 
period if 
retrospective
At least 4-6 months 
before and alter the 
intervention
Type of patient 
care data
Prospective Prospective Prospective
Prospective (if 
necessary)
* Adopted from How to investigate drug use in health facilities: Selected drug use indicators, 
WHO/DA P/93.11.
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The methodology adopted was an indicator based retrospective and prospective 
observational study. Qualitative and quantitative assessment was done through the 
review o f historical data, interviews and meetings with key players, and direct 
observation o f current practice.
The tools which were used to collect and analyse data were adapted from those 
developed by World Health Organisation (WHO) 1 and Health Systems Trust3031. 
These included the following: -
• A set o f drug supply management indicators listed in Appendix B 1 (page 81).
• Tracer Standard Operating Procedures (SOPs) listed in Table 2.2 below, which 
were adopted from the guidelines, developed by Gray30. Their availability was 
used to indicate existence o f written procedures to guide Drug Supply 
management.
• Tracer drugs/non-drug items listed in Table 2.3 (page 14), which were adopted 
from WHO1 and HST30'31 guidelines. They represent the key drugs and items 
needed to render a basic Primary Health Care service. They were used to 
assess drug logistics indicators as outlined in Appendix B3 (Pages 85-86).
Table 2.2 Tracer Standard Operating Procedures
1. How to maintain a Cold Chain at a PHC facility
2. How to organise the medicine and supplies store
3. How to maintain drug use records
4. How to control Schedule 5,6 & 7 substances
5. How to order supplies from the sub-depot
6. How to receive supplies at the PHC facility
7. How to dispose o f expired medicines
8. How to handle a Product Recall
9. How to control Pests from a medicine store
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Table 2.3 Tracer Drugs and Non-Drug Items*
Drugs
Amoxycillin caps 250mg 15s Glibenclamide tabs 5mg 28s
Amoxycillin caps 250mg 30s Glibenclamide tabs 5mg 56s
Amoxycillin caps 250mg 100s Glibenclamide tabs 5mg 500s
Amoxycillin susp 125mg/5ml 100ml Metronidazole tabs 200mg 28s
Ciprofloxacin tabs 500mg 10s Metronidazole tabs 200mg 21s
Penelente injection 2.4 mU Metronidazole tabs 200mg 250s
Paracetamol Syrup 120mg/5ml 50ml Paracetamol tabs 500mg 10s
Paracetamol Syrup 120mg/5ml 100ml Paracetamol tabs 500mg 20s
Ibuprofen tabs 200mg 15s Paracetamol tabs 500mg 500s
Ibuprofen tabs 200mg 28s Adrenaline injection
Ibupro fen tabs 200mg 42s ORS Sachets
Ibuprofen tabs 200mg 56s Salbutamol inhaler
Ibuprofen tabs 200mg 1000s Tetanus Vaccine
HCTZ tabs 25mg 14s Ringers Lactate IV
HCTZ tabs 25mg 28s
HCTZ tabs 25mg 500s
Non-Drug Items
IV Admin. Set 10 Drops Insulin syringe 0.5ml
IV Admin. Set 15 Drops Syringe 2ml
IV Admin. Set 20 Drops Blue Needles (EPI)-lOOs
IV Admin. Set 60 Drops Gloves non-sterile small-100s
Glucose/Ketones Test Strip Gloves non-sterile medium-100s
Insulin syringe 1ml Gloves non-sterile large-10s
* Adopted from WHO and Health Systems Trust guidelines1'30, as well as the NMTTS study32 and 
adapted to the study with input from the Health staff of Tshwane. The different pack sizes were 
assessed separately because in most cases, they reflected a different treatment guideline
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• Structured questionnaires for the Facility Manager (Appendix B4, page 87) 
and Sub-depot Manager (Appendix B5, page 93). These were adopted from 
HST guidelines30 and were used to collect general information about 
personnel, physical facilities, and routine operations.
These tools have been tested locally32'34and internationally1’11,12,26 and standardised to 
generate reliable and comparable data. They were adapted to the study through 
comments by health staff o f  Tshwane and a pilot study at two clinics in Tshwane. 
These included considering different pack sizes o f different drugs and non-drug tracer 
items because these represented different indications. Blue needles for immunisation 
were added since immunisation was one o f the main activities o f  the local authority 
clinics.
2.3.Sample Size
2.3.1. Selection of Health Facilities
There were four sub-depots (two Independent Sub-depots and two Hospital 
pharmacies) and fifty-eight Primary Health Care facilities in Tshwane at the time. 
WHO guidelines for a basic cross-sectional study design require a sample o f at least 
twenty Health facilities. However, at the request o f  the Tshwane Drug Task Team, all 
the facilities were included in the study in order to avoid the limitation o f inadequate 
sample size associated with the audit done by Stafford et a f.  Apart from Moretele 
District, the clinics under other authorities were more than 10 as shown in Table 2.4 
(page 16), which would allow comparisons between authorities as recommended 
under the WHO guidelines1 (Table 2.1, page 12).
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Table 2.4 Distribution of Health Facilities by Type and Authority
Authority Pharmacy No. of Clinics No. of CHC Total No. of Clinics
Gauteng PRP 14 3 17
CTMM CTMM Sub-depot 22 0 22
Moretele Jubilee Pharmacy 5 3 8
Odi Odi Pharmacy 8 3 11
Total 4 49 9 58
PRP = Pretoria Regional Pharmacy, CTMM = City o f Tshwane Metropolitan 
Municipality, CHC = Community Health Centre
2.3.2. Selection of Patient Prescribing Encounters
Prescribing encounters were sampled retrospectively by drawing random encounters 
from historical medical records over a period o f one year from date o f survey. At 
least thirty encounters per clinic were randomly selected as follows 1: -
a. The chronological listings, by date, o f all patient visits made during the past 
year were identified either from the Clerks’ Attendance Registers or Daily 
Clinic Registers maintained by Prescribers.
b. The sampling interval was calculated by dividing the number o f days in the 
sample frame (365 days) by the number o f encounters to be selected (30). i.e. 
365/30=12.2.
c. Sampling began at the first day in the chronological sample frame, i.e. 1st day, 
(1+12.2=13.2, rounded up) 14th day, (13.2+12.2=25.4, rounded up) 26th day, 
and so forth.
d. From each selected day a single encounter was picked at random by 
multiplying the total number o f encounters listed for that day by a random 
number between 0.0 and 1.0, and rounded upwards.
Step (b) to (d) were performed quickly using Microsoft Excel computer programme.
1 6
A pilot study was done at Laudium Community Health Centre and East Lynne in 
order to clarify data sources, the suitability o f the tools and estimate the time required 
to collect data per facility. The pilot study indicated that one day per clinic and two 
days per Community Health Centre (CHC) was optimal for data collection. A 
schedule o f  visits, including a proposed programme o f the day at the facility, was 
made available to all the health facilities included in the study (Appendix C, page 
101). A telephone call was made to the clinic at least one week prior to the visit to 
confirm suitability o f  the scheduled date.
2.4.1. Assessment of Facilities for Drug Supply Management
On the day o f the visit to the facility, a questionnaire in Appendix B4 (page 87) was 
administered to the person in-charge o f the health facility. A guided tour o f the health 
facility was made to assess the availability and condition o f the facilities for Drug 
Supply Management. Findings were recorded on the structured questionnaire.
2.4.2. Assessment of Prescribing Indicators
A sample o f thirty prescribing encounters from records o f patients who attended the 
facility during the past year was randomly selected and the details per encounter 
recorded directly on computer in the prescribing indicators form as shown in 
Appendix B2 (page 84).
2.4.3. Assessment of Logistics Performance Indicators
Stock cards, delivery notes and invoices were reviewed and a physical count was done 
to collect information on each tracer item as outlined on Logistics Performance 
Indicators form (Appendix B3, pages 85 - 86). The findings were recorded on the 
same form.
2.4.Planning and Field Assessment Methods
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2.5.Performance Targets
Performance targets as listed in Table 2.5 below were used to assess Drug Supply 
Management in Tshwane. They were adopted taking into consideration the following:
• Recommendations from WHO1
• Examples o f targets used in earlier studies in South Africa32‘34and other
. 11 l?countries '
•  Principles o f  the South African National Drug Policy35 (and the Essential 
Drugs Programme) as interpreted in the Standard Treatment Guidelines (STG) 
and Essential Drug list (EDL)36.
Table 2.5 Performance Indicators and Performance Targets
Performance Indicator Performance Target
Average number o f drugs prescribed per patient <2
% o f drugs prescribed by generic name 100%
% o f patient-encounters with an antibiotic prescribed <25%
% of patient-encounters with an injection prescribed <15%
% o f prescribed drugs that are on the EDL 100%
% of ordered items that are supplied within the stipulated schedule >95%
% o f tracer items in stock >90%
% of tracer items out o f stock at least once in a year <10%
% of tracer items where physical stock = quantity on record 100%
2.6.Null Hypotheses
The following hypotheses were used to identify the factors responsible for the 
weaknesses observed. These were based on the preliminary discussions by the 
Tshwane Drug task Team.
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i. The category o f staff responsible for Drug Supply Management does not affect 
the status o f Drug Supply Management at the clinic, as measured using WHO 
and HST Drug Supply Management Indicators
ii. The number o f staff trained in Drug Supply Management, Rational Drug Use 
(RDU) and Cold Chain Management (CCM) has no impact on the status o f 
Drug Supply Management, as measured using WHO and HST Drug Supply 
Management Indicators
iii. Rotation o f the person in-charge o f Drug Supply Management has no impact 
on the status o f Drug Supply Management, as measured using WHO and HST 
Drug Supply Management Indicators
iv. A formal quantification method does not improve availability o f drugs at the 
clinic
v. There is no difference in availability o f drugs between clinics supplied by 
independent pharmacies (sub-depots) and Hospital pharmacies.
2.7.Data Handling and Analysis
The unit o f analysis was the health facility. All filled questionnaires and forms were 
checked on the day o f data collection for accuracy, consistency and adequacy. They 
were then kept in a dedicated file. All data on the standard indicator forms was 
entered in similar forms in Microsoft Excel Program on the computer. From these 
forms, health facility summaries were calculated and entered on the Drug Supply 
Management Indicators Consolidation form (Appendix B6, page 100). Qualitative and 
quantitative data from the questionnaires was summarized on the Qualitative Data 
Summary form as shown in Table A8 (pages 74).
The discussion o f results followed indicator groups. First the expected performance 
standard was briefly described followed by a comparison o f results with standard
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performance targets and observations from other studies done in South Africa and 
other countries. The following statistics were used to analyze the data: -
• Descriptive statistics to describe the status o f Drug Supply Management .
•  Pearson correlation coefficient, r, to assess whether there was a relationship 
between the number o f staff trained and some quantitative indicators. This 
indicates the measure o f intensity o f linear relationship between two variates. It 
varies from -1 to +1 corresponding to perfect negative correlation and perfect
"5*7
positive correlation . A positive correlation indicates that the variables increase 
together, while a negative correlation indicates that as one variable increases, the 
other decreases38.
• For comparison between groups, the following were used ’ : -
>  The two-sided F test for a difference between two independent variances.
>  The two-sided t test for a difference between two independent means.
>  The two-sided z test or upper tail %2( 1) test for a difference between two 
independent proportions, as applicable.
Calculations were performed manually and crosschecked using Microsoft Excel 
Program for those statistics supported by the program. A 5% level o f significance 
(95% confidence level) was used as expected from this WHO methodology1. The 
differences were noted in their absolute terms but were only considered significant if 
p>0.05. However, Utts cautions that a very strong relationship will not necessarily 
achieve statistical significance if the sample is small38.
There was justification to assume the same level o f confidence since the WHO 
methodology was used and the sample o f  health facilities and patient encounters 
evaluated was more than the recommended minimum.
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2.8.Constraints and Limitations
i. Although the target was to cover fifty-eight health facilities in Tshwane, only 
thirty-nine were covered. Three facilities, though visited, were not included in the 
analysis because they belong to Metsweding and not Tshwane. Some facilities 
were not visited either because the key personnel or researcher was not available 
on the scheduled date. The data collection was terminated prematurely at the 
request o f the sponsor following a presentation o f an interim analysis. 
Nevertheless, data from thirty-six health facilities (62%) was analysed and twenty 
facilities is the minimum number required for a basic cross-sectional design, 
which was used in this study1. Therefore, the accuracy and reliability attained in 
this study is likely to be better than that anticipated through the WHO 
recommended sample size and methodology1. The remaining limitation is that 
these facilities were not randomly selected. For a comparative cross-sectional 
analysis, it is recommended that each group should have at least ten facilities 
(Table 2.1, page 12). This was not the case for Moretele (six) and Odi (five) 
districts. Therefore, the trends rather than the absolute figures should be 
considered where comparison between authorities is made. In order to make some 
group comparison, the option was to consider clinics under Moretele and Odi 
districts as one group. Although this would make sense (since they all belong to 
North West Province), the fact that they are supplied from different sources may 
impart intra-group differences.
ii. The records o f all patients seen on the selected day were not always available. In 
some cases, the patients were listed in several books and there was no clear 
chronological order to use in sampling. All the available records o f the day were 
nevertheless used in the sampling. Since the recording by the clerks was random,
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absence o f one book from one clerk could not have had any significant effect on 
the sampling plan.
iii. The actual date o f ordering stock could not be ascertained at some facilities. 
Facilities often ordered early so that their order could reach the sub-depot by the 
scheduled date. In such incidences, the scheduled order date was used. This would 
mean that the actual lead time was longer than observed. Since the observed lead 
time was longer than the ideal target o f  seven days (five working days), the 
observations made about lead time are still valid.
iv. In assessing whether the drug prescribed was on the Essential Drug List (EDL), 
only the name was considered. The study did not assess whether the prescription 
complied with the Standard Treatment Guidelines for Primary Health Care 
facilities in respect to indication, dose and duration o f treatment. This is an area 
for further study.
v. The study did not assess the linkage between the type o f prescriber and the 
prescribing indicators. The Ugandan study by Kafuko et al, 26 showed that the type 
o f prescriber had an influence on the observed prescribing indicators. This is an 
area for further study.
vi. Data was collected based on the cross-sectional descriptive study as requested by 
the Tshwane Drug Task Team, without specifically catering for the hypotheses 
that have been included for the purpose o f the research report. The sample size in 
some comparison groups was too small to allow use o f certain statistical tests. 
Nevertheless, use o f appropriate statistical analysis and interpretation with caution 
has ensured that the conclusions made are valid. Utts states that strong 
relationship will not necessarily achieve statistical significance if the sample is 
very small38. This should be borne in mind when interpreting the p values.
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3. RESULTS
Prospective data was collected between September and December 2002 while 
retrospective data covered the period from July 2001 to the day o f data collection 
(approximately one year). Results are reported in three major sections. The first one 
gives the characteristics o f  the sample included in the evaluation. The second section 
gives the status o f Drug Supply Management presented according to indicator groups. 
Each section on indicator group begins with a table o f results followed by text 
highlighting key findings. The third section presents results according to the factors 
being evaluated under the null hypotheses.
3.1.Sample Characteristics
Table 3.1 below shows the distribution o f clinics in the planned sample and those 
included in the evaluation.
Table 3.1 Distribution of Health Facilities from which Data was Analysed
Authority Pharmacy Unit No. of Clinics No. ofCHCs
Total
No %
Gauteng PRP
Plan 14 3 17 29.3%
Actual 8 3 11 30%
CTMM CTMM Sub- depot
Plan 22 0 22 37.9%
Actual 14 0 14 38.9%
Moretele JubileePharmacy
Plan 5 3 8 13.8%
Actual 4 2 6 16.7%
Odi Odi Pharmacy
Plan 8 3 11 19.0%
Actual 2 3 5 13.9%
Total 4
Plan 49 84.5% 9 15.5% 58 100%
Actual 28 77.8% 8 22.2% 36 62%
Data from all four sub-depots and thirty-six health facilities (62%) was analysed. 
These are more than the minimum o f twenty required for a basic cross-sectional study 
design as recommended by WHO1. However, only Gauteng Provincial Authority and
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City o f Tshwane had more than the minimum ten clinics to allow comparison between 
the groups1. The proportion o f clinics by type and authority in the analysed sample 
did not differ significantly from the population (p >0.05) (table 3.1, page 23).
Table A1 (page 66) shows that a total o f 1286 patient encounters were analysed in the 
whole study out o f which 965 (75%) were retrospective and 321 (25%) were 
prospective. This is well above the required 600 patient encounters to achieve 
sufficiently accurate and reliable estimates'.
3.2.Status of Drug Supply Management 
This section includes indicators for the resources required for effective Drug Supply 
Management (facility indicators; control o f medicine budget indicators; efficiency of 
suppliers indicators; drug procurement, availability and control indicators; personnel 
indicators) and the core drug use indicators (Cold Chain Management indicators, 
Prescribing indicators and Patient Care indicators).
3.2.1. Facility Indicators
The facility indicators are presented in Table A2 (page 67) and summarized in Table 
3.2 (page 25). The phrasing o f the indicator in the heading shows the expected norm. 
The following observations have been singled out for mention because they depend 
on the human factor and were used later to assess the differences between groups.
• In 38.9% o f the clinics stock was found placed directly on the floor.
• Restricted access to the drug store was practiced at 44.4% o f the clinics.
From qualitative observations, it was noted that most facilities under the City o f 
Tshwane did not have a store separate from the dispensary. Although most facilities 
under Gauteng Provincial Authority had a drug store, they did not have a central 
dispensary and so used the consultation room for dispensing.
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Table 3.2 Indicators for Storage Facilities
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Sub-depots
Number, n= 4 2 1 2 3 3 3 4 2 1 1
Percentage (%) 50 25 50 75 75 75 100 50 25 25
PHC Facilities
GPA (n = ll) No 1 2 7 9 8 3 8 6 9 1
% 9.1 18.2 63.6 81.8 72.7 27.3 72.7 54.5 81.8 9.1
CTMM
(n=14)
No 2 10 6 11 12 0 8 8 14 3
% 14.3 71.4 42.9 78.6 85.7 0.0 57.1 57.1 100 21.4
MORETELE & 
ODI (n = ll)
No 0 3 3 0 3 0 5 8 1 0
% 0.0 27.3 27.3 0.0 27.3 0.0 45.4 72.7 9.1 0.0
TOTAL
(n=36)
No 3 15 16 20 23 3 21 22 24 4
% 8.3 41.7 44.4 55.6 63.9 8.3 58.3 61.1 66.7 11.1
Municipality, GPA = Gauteng Provincial Authority, V = Yes, X = No.
3.2.2. Drug Supply Management Indicators for Sub-depots
The Drug Supply Management indicators for the major suppliers are presented in
table 3.3 (page 26). These results show that: -
• the service level (% o f drugs ordered that are supplied within the delivery 
schedule) o f  the sub-depots that supply Primary Health Care facilities from their 
respective Provincial Depots was above 94%
• the availability o f tracer items ranged from 76% at City o f Tshwane Metropolitan 
Municipality sub-depot to 100% at Jubilee Hospital pharmacy
• the service level o f  the sub-depots to the Primary Health Care clinics ranged from 
67% by Odi Hospital Pharmacy to 85% by Pretoria Regional Pharmacy.
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Table 3.3 Summary of Drug Supply management Indicators for the Sub-depots
Indicator
Pretoria
Regional
Pharmacy
CTMM
sub-depot
Jubilee
Hospital
Pharmacy
Odi
Hospital
Pharmacy
Current
Staffing
Pharmacists 7 1 3 3
Pharmacist’s
Assistants 4 5 8 12
Others 15 13 6 4
Supplier Auckland Park
Auckland
Park/Private
Suppliers
Vuna
Healthcare
Logistics
Vuna
Healthcare
Logistics
Facilities
supplied
Clinics 22 31 26 23
Other public 32 6 2 1
Psych drugs 
scripts/month -6000 0 0 0
Private 250 89 0 0
Mean supplier Lead time 
in days (Range)
37
(7 to 215)
15
(1 to 45)
2
(2 to 3)
4
(4 to 4)
Ordering interval in days 
(Range)
88
(13 to 378)
97
(7 to 276) -
8
(7 to 13)
% last order supplied 100 120* - 94
% Tracer drugs in stock 85 76 100 97
% items o/s in past yr 60 21 - -
% ROL determined 100 100 100 100
Inventory control Stock cards Stock cards Computer Computer
Stock/card=Stock/shelf 50% - - -
Storage conditions Inadequate Adequate Inadequate Fair
Lead time to clinics 8 14 12 8
No o f items on supply 
list 406 627? 245* 245*
Service level to clinics
(%)
85 81 77 67
Prepackaging Fair Adequate Inadequate Fair
Operate “Back order” No Yes Yes No
% o f Expired/Budget for 
2001/2 R24,776,251^ 220% R8,274,000^ 122%
Value o f expired drugs in 
Rands (%Budget) 
in2001/2
~R500,000
(2%)¥
Not
available
R18,936.02£
(0.23%)£
R13,584.61 
(0.20%)
figures for 2001/2 not available, figures are for expenditure, figu re  for expire drugs from 
April to October 2002 and % of expenditure over the same period. ^Figure includes 75 bulk 
packs, 16 duplicate factory & pre-packed patient packs, and non-medical items. vAs a 
percentage of expenditure, * Includes back orders because system could not differentiate back­
orders from current order, CTMM 
Psychotropic
City of Tshwane Metropolitan Municipality. Psych
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The indicators and performance targets for drug procurement, availability and control 
are presented in Table A3 (page 68) and summarized in Table 3.4 below.
Table 3.4 Summary of Indicators for Drug Procurement, Availability & Control
3.2.3. Drug Procurement, Availability and Control Indicators
(Summarised from Table A3, page)
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Mean 11.2 79.0 56.1 33.1 33.8 87.6 55.9
Maximum 23.2 97.7 126.4 83.3 100.0 100.0 100.0
Minimum 3.4 57.7 16.5 0.0 0.0 70.0 8.3
Performance
Target Yes Adequate - >95 - <10
ROL/Min-
Max 100 >90 Yes 100
% of clinics which 
meet target 47 56 - 4 - 7 53 3 58 67 4
SOPs = Standard operating procedures, O/S = Out o f  stock, ROL = Re-Orc er Leve 1
Min-Max = Minimum-Maximum level, Card=Shelf means the balance quantity on the 
card was equal to the quantity physically on the shelf.
The major findings were: -
• Only 47% o f the clinics had the entire tracer Standard Operating Procedures.
• The method o f quantification o f drugs was found to be adequate at 53% of the 
clinics.
• Only 56% o f the clinics had adequate receiving procedures.
• Out o f 36 facilities visited, 24 (67%) used stock cards. On average physical stock 
on the shelf was found to be equal to the balance quantities on the stock card only 
in 55.9% (range 8.3% to 100%) o f the tracer items.
• On average 33.1% (range 0% to 83.3%) o f the tracer items had been out o f stock 
at least once in the past year.
• On the day o f the study, on average 87.6% (range 70% to 100%) o f the tracer item 
were in stock.
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Once drugs are available at the clinic and there are adequate facilities, professional 
guidelines require that they should be managed full time by someone with basic 
training in Pharmacy and/or further training in Drug Supply Management.
Information on personnel responsible for Drug Supply Management and their training 
is presented in Table 3.5 (page 29). It shows that Pharmacist’s Assistants (PAs) were 
in-charge o f Drug Supply Management at seven facilities (19%). Although each 
Pharmacist’s Assistant had a base clinic, most Pharmacist’s Assistants were each 
assigned two to three facilities thereby rotating between them and concentrating on 
none.
Nursing personnel were in charge o f Drug Supply Management at most (81%) o f the 
facilities. These were mainly Registered Nurses (RNs) (66.7%). In some facilities, an 
Enrolled Nurse (EN) was assigned to work in the drug store and dispensary, under 
supervision o f a Registered Nurse. Nurses who were assigned Drug Supply 
Management responsibilities also performed clinical duties. They reported that Drug 
Supply Management was not viewed as a primary function. It was thus attended to 
last.
Most o f the clinics had at least one staff trained in Drug Supply Management (88%), 
or Rational Drug Use (82%) or Cold Chain Management (79%).
Drug Supply Management was performed on a rotational basis in 18 (50%) o f the 
facilities visited and on a permanent basis in the other 18 (50%) facilities. In most 
facilities, no person had the full-time responsibility for Drug Supply Management.
3.2.4. Personnel for Drug Supply Management and their Training
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Table 3.5 Personnel Indicators Related to Drug Supply Management at Clinics
Facility
Type Owner I/C of DSM No. Trained
Qualification Duration DSM RDU CCM
Boikhutsong Clinic GPA Reg.Nurse Permanent 4 10 10
Bophelong Clinic GPA Reg.Nurse Permanent 1 0 1
Eesterust Clinic GPA Reg.Nurse Permanent 8 7 ND
Laud iu m CHC GPA Reg.Nurse Rotation 4 16 16
Mandisa Shiceka Clinic GPA Reg.Nurse Rotation 5 0 5
Pretoria North Clinic GPA Reg.Nurse Permanent 1 17 4
Skinner Street Clinic GPA Reg.Nurse Permanent 10 0 10
Soshanguve 3 CHC GPA Reg.Nurse Rotation 4 ND 3
Soshanguve JJ Clinic GPA Reg.Nurse Permanent 1 1 7
Stanza Bopape CHC GPA Enrld Nurse Rotation 3 11 3
Sedibeng HC Clinic GPA Reg.Nurse Permanent 1 2 0
Jubilee Gateway Clinic Moretele Reg.Nurse Rotation 1 1 0
New Eersterust Clinic Moretele Reg.Nurse Rotation 0 1 1
Ramotse Clinic Moretele Enrld Nurse Rotation 1 1 1
Refentse CHC Moretele Reg.Nurse Permanent 1 0 0
Suurman Clinic Moretele Enrld Nurse Permanent 2 2 2
Temba CHC Moretele Enrld Nurse Rotation 11 11 11
Boekenhout CHC ODI Reg.Nurse Rotation 6 6 6
Itireleng Clinic ODI Reg.Nurse Permanent 0 0 0
Kgabo CHC ODI Enrld Nurse Permanent 16 16 27
Mpho ya Batho Clinic ODI Reg.Nurse Rotation 2 0 0
Phedison I CHC ODI Reg.Nurse Rotation 4 1 0
Atteridgeville Clinic CTMM Pharm Asst Rotation 1 5 6
Danville Clinic CTMM Pharm Asst Rotation 1 3 1
Folang Clinic CTMM Pharm Asst Rotation 1 10 1
Gazankulu Clinic CTMM Reg.Nurse Permanent ND 1 1
Hercules Clinic CTMM Reg.Nurse Permanent 3 3 3
Karenpark Clinic CTMM Reg.Nurse Permanent 1 4 0
Laudium Clinic CTMM Reg.Nurse Permanent 0 5 5
Lyttelton Clinic CTMM Reg.Nurse Permanent 1 6 1
Mamelodi West Clinic CTMM Pharm Asst Permanent ND ND ND
Phahameng Clinic CTMM Pharm Asst Rotation 1 5 5
Phomolong Clinic CTMM Pharm Asst Rotation 1 6 2
Rosslyn Clinic CTMM Reg.Nurse Permanent 1 5 1
Silverton Clinic CTMM Reg.Nurse Rotation 0 3 1
Stanza Bopape 2 Clinic CTMM Pharm Asst Rotation 2 10 8
Performance Target ((£> clinic) Pharm Asst Permanent >1 >1 >1
% of clinics which comply 19% 50% 88% 82% 79%
I/C = In-charge, DSM = Drug Supply Management, RDU = Rational Drug Use,
CCM = Cold Chain Management, ND = No data, CTMM = City of Tshwane Metropolitan 
Municipality, GPA = Gauteng Provincial Authority, Reg = Registered, Enrld = Enrolled, 
Pharm. Asst = Pharmacist’s Assistant
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3.2.5. Cold Chain Management Indicators
The ideal way to maintain a vaccine cold chain is to use a standard Expanded 
Programme for Immunisation (EPI) fridge, record the fridge temperature daily using a 
Minimum-Maximum thermometer, avoid keeping stock in the fridge door and avoid 
using the vaccine fridge to store food and drinks.
Result presented in table 3.6 (page 31) show that only 35% (12 out o f 34) o f fridges 
were standard Expanded Programme for Immunisation fridges. Most o f the clinics 
(85%) recorded the fridge temperature daily, though only 45% used the Minimum- 
Maximum thermometer. Other facilities used a normal thermometer and recorded the 
fridge temperature twice daily to try and capture the coolest and hottest times o f the 
day. In 18% o f the clinics with a fridge, stock was found stored in the fridge door 
while in 9% o f the clinics, food or drinks were found stored in the vaccine fridge.
3.2.6. Prescribing Indicators
This group o f indicators was evaluated in thirty-three clinics. The prescribing 
indicators together with their performance targets are shown in table 3.7 (page 32). It 
shows that: -
• The average number o f drugs per patient encounter was 2.27 (range: 1.57 to 3.67).
• On average 51.6% (range 12.5% to 98.0%) o f the drugs were prescribed by 
generic name.
• At least one antibiotic was prescribed in, on average, 35% (range 0% to 65.5%) of 
all patient encounters.
• On average, 17.2% (range 0% to 46.7%) o f all patient encounters received an 
injection.
• On average 95.6% (range 81.8% to 100%) o f drugs prescribed were on the 
Essential Drug List for Primary Health Care facilities.
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Table 3.6 Cold Chain Management Indicators
Facility Type Owner
Ty pe of Fridge Cold Chain Management
EPI Dom Hasfridge
Stock in 
door
Food in 
Fridge Daily
Therm
Type
Power
Back-up
Boikhutsong Clinic GPA No
Bophelong Clinic GPA Yes Yes No No Yes Normal Yes
Eesterust Clinic GPA Yes Yes Yes No No None No
Laudium CHC GPA Yes Yes No No Yes Min-Max Yes
Mandisa Shiceka Clinic GPA Yes Yes No No Yes Normal No
Pretoria North Clinic GPA Yes Yes No No Yes Normal No
Skinner Street Clinic GPA Yes Yes No Yes Yes Normal No
Soshanguve 3 CHC GPA Yes Yes No No Yes Normal Yes
Soshanguve JJ Clinic GPA Yes Yes No Yes No None No
Stanza Bopape CHC GPA Yes Yes No No Yes Min-Max Yes
Sedibeng HC Clinic GPA No
Jubilee Gateway Clinic Moretele Yes Yes Yes No Yes Normal Yes
New Eersterust Clinic Moretele Yes Yes Yes No Yes Normal No
Ramotse Clinic Moretele Yes Yes No No No Normal No
Refentse CHC Moretele Yes Yes No No Yes Normal No
Suurman Clinic Moretele No
Temba CHC Moretele Yes Yes Yes No Yes Normal No
Boekenhout CHC ODI Yes Yes No No No Normal No
Itireleng Clinic ODI Yes Yes No No No Normal No
Kgabo CHC ODI Yes Yes No No Yes Normal No
Mpho ya Batho Clinic ODI Yes Yes No No Yes Normal No
Phedison I CHC ODI Yes Yes No No Yes Normal No
Atteridgeville Clinic CTMM Yes Yes No No Yes Min-Max No
Danville Clinic CTMM Yes Yes No No Yes Min-Max No
Folang Clinic CTMM Yes Yes Yes No Yes Min-Max Yes
Gazankulu Clinic CTMM Yes Yes No No Yes Min-Max No
Hercules Clinic CTMM Yes Yes No Yes Yes Min-Max No
Karenpark Clinic CTMM Yes Yes No No Yes Min-Max No
Laudium Clinic CTMM Yes Yes No No Yes Min-Max No
Lyttelton Clinic CTMM Yes Yes Yes No No Yes Min-Max No
Mamelodi West Clinic CTMM Yes Yes Yes No Yes Min-Max No
Phahameng Clinic CTMM Yes Yes No No Yes Min-Max No
Phomolong Clinic CTMM Yes Yes No No Yes Min-Max No
Rosslyn Clinic CTMM Yes Yes No No Yes Normal No
Silverton Clinic CTMM Yes Yes No No Yes Min-Max No
Stanza Bopape 2 Clinic CTMM Yes Yes No No Yes Min-Max No
Performance Target ((a), clinic) Yes Yes No No Yes Min-max Yes
% of clinics which comply 36% 92% 82% 91% 85% 45% 18%
Dom = Domestic, Therm = Thermometer, EPI = Expanded Programme for 
Immunisation, CTMM = City o f Tshwane Metropolitan Municipality, GPA =
Gauteng Provincial Authority
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Table 3.6 Cold Chain Management Indicators
Facility Type Owner
T> pe of Fridge Cold Chain Management
EPI Dom Hasfridge
Stock in 
door
Food in 
Fridge Daily
Therm
Type
Power
Back-up
Boikhutsong Clinic GPA No
Bophelong Clinic GPA Yes Yes No No Yes Normal Yes
Eesterust Clinic GPA Yes Yes Yes No No None No
Laudium CHC GPA Yes Yes No No Yes Min-Max Yes
Mandisa Shiceka Clinic GPA Yes Yes No No Yes Normal No
Pretoria North Clinic GPA Yes Yes No No Yes Normal No
Skinner Street Clinic GPA Yes Yes No Yes Yes Normal No
Soshanguve 3 CHC GPA Yes Yes No No Yes Normal Yes
Soshanguve JJ Clinic GPA Yes Yes No Yes No None No
Stanza Bopape CHC GPA Yes Yes No No Yes Min-Max Yes
Sedibeng HC Clinic GPA No
Jubilee Gateway Clinic Moretele Yes Yes Yes No Yes Normal Yes
New Eersterust Clinic Moretele Yes Yes Yes No Yes Normal No
Ramotse Clinic Moretele Yes Yes No No No Normal No
Refentse CHC Moretele Yes Yes No No Yes Normal No
Suurman Clinic Moretele No
Temba CHC Moretele Yes Yes Yes No Yes Normal No
Boekenhout CHC ODI Yes Yes No No No Normal No
Itireleng Clinic ODI Yes Yes No No No Normal No
Kgabo CHC ODI Yes Yes No No Yes Normal No
Mpho ya Batho Clinic ODI Yes Yes No No Yes Normal No
Phedison I CHC ODI Yes Yes No No Yes Normal No
Atteridgeville Clinic CTMM Yes Yes No No Yes Min-Max No
Danville Clinic CTMM Yes Yes No No Yes Min-Max No
Folang Clinic CTMM Yes Yes Yes No Yes Min-Max Yes
Gazankulu Clinic CTMM Yes Yes No No Yes Min-Max No
Hercules Clinic CTMM Yes Yes No Yes Yes Min-Max No
Karenpark Clinic CTMM Yes Yes No No Yes Min-Max No
Laudium Clinic CTMM Yes Yes No No Yes Min-Max No
Lyttelton Clinic CTMM Yes Yes Yes No No Yes Min-Max No
Mamelodi West Clinic CTMM Yes Yes Yes No Yes Min-Max No
Phahameng Clinic CTMM Yes Yes No No Yes Min-Max No
Phomolong Clinic CTMM Yes Yes No No Yes Min-Max No
Rosslyn Clinic CTMM Yes Yes No No Yes Normal No
Silverton Clinic CTMM Yes Yes No No Yes Min-Max No
Stanza Bopape 2 Clinic CTMM Yes Yes No No Yes Min-Max No
Performance Target (@ clinic) Yes Yes No No Yes Min-max Yes
% of clinics which comply 36% 92% 82% 91% 85% 45% 18%
Dom = Domestic, Therm = Thermometer, EPI = Expanded Programme for 
Immunisation, CTMM = City o f  Tshwane Metropolitan Municipality, GPA =
Gauteng Provincial Authority
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Table 3.7 Prescribing Indicators
Ser.No Facility Type Owner Drugs/Pt %Generics %ABs % Injections %on EDL
1 Boikhutsong Clinic GPA 2.59 64.0 65.5 6.9 98.7
2 Bophelong Clinic GPA 2.83 52.9 24.1 10.3 100.0
3 Eesteaist Clinic GPA 2.00 12.5 0.0 25.0 100.0
4 Laudium CHC GPA 3.63 52.0 48.1 22.2 92.9
5 Mandisa Shiceka Clinic GPA - - - - -
6 Pretoria North Clinic GPA 2.62 46.1 17.2 3.4 94.7
7 Skinner Street Clinic GPA 3.07 38.0 33.3 10.0 100.0
8 Soshanguve 3 CHC GPA 2.07 45.2 44.8 34.5 100.0
9 Soshanguve JJ Clinic GPA 1.87 37.5 53.6 3.6 96.4
10 Stanza Bopape CHC GPA 2.13 39.1 33.3 13.3 100.0
11 Sedibeng HC Clinic GPA 3.67 39.1 50.0 0.0 100.0
12 Jubilee Gateway Clinic Moretele 2.00 66.7 33.3 6.7 86.7
13 New Eersterust Clinic Moretele 2.87 47.7 56.7 10.0 98.8
14 Ramotse Clinic Moretele 2.03 62.3 26.7 23.3 98.4
15 Refentse CHC Moretele 2.03 82.0 36.7 6.7 98.4
16 Suurman Clinic Moretele 1.57 80.9 20.0 0.0 100.0
17 Temba CHC Moretele 1.67 52.0 30.0 33.3 96.0
18 Boekenhout CHC Odi 1.87 69.6 33.3 10.0 98.0
19 Itireleng Clinic Odi 2.83 42.4 46.7 6.7 89.4
20 Kgabo CHC Odi 1.83 58.2 30.0 16.7 98.2
21 Mpho Ya Batho Clinic Odi 1.80 42.6 10.0 13.3 90.7
22 Phedisong 1 CHC Odi 1.83 47.3 40.0 6.7 94.5
23 Atteridgeville Clinic CTMM 1.83 32.7 50.0 33.3 81.8
24 Danville Clinic CTMM 2.36 56.1 29.6 37.0 98.5
25 Folang Clinic CTMM 2.33 38.6 64.3 7.1 98.6
26 Gazankulu Clinic CTMM 1.85 60.4 15.4 42.3 93.6
27 Hercules Clinic CTMM 2.50 50.7 16.7 40.0 93.3
28 Karenpark Clinic CTMM 1.97 96.6 39.3 17.9 100.0
29 Laudium Clinic CTMM 2.20 22.7 40.0 10.0 93.9
30 Lyttelton Clinic CTMM - - - - -
31 Mamelodi West Clinic CTMM 2.40 40.0 25.0 25.0 91.7
32 Phahameng Clinic CTMM 2.57 29.9 43.3 26.7 93.5
33 Phomolong Clinic CTMM 2.23 55.2 13.3 46.7 91.0
34 Rosslyn Clinic CTMM 1.63 98.0 57.7 7.7 89.8
35 Silverton Clinic CTMM 2.13 43.8 26.7 10.0 98.4
36 Stanza Bopape 2 Clinic CTMM - - - - -
Mean 2.27 51.6 35.0 17.2 95.6
Maximum 3.67 98.0 65.5 46.7 100.0
Minimum 1.57 12.5 0.0 0.0 81.8
Performance target <2 100 <25 <15 100
% of Clinics which meet the target 39% 0% 27% 58% 24%
‘or Clinics in Tshwane
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3.3.Impact of Various Factors on the Status of Drug Supply 
Management in Tshwane
In order to assess the impact o f various factors on the status o f Drug Supply 
Management in Tshwane, several hypotheses were used.
3.3.1. Effect of Category of Staff (Pharmacist’s Assistant versus Nurse) 
on Drug Supply Management Indicators
Table 3.8 (derived from Table A5 [page 71] and Table A8 [pages 74-79]) below 
shows that a Pharmacist’s Assistant was in charge o f Drug Supply Management at 
seven clinics and a nurse was in charge at twenty-nine clinics.
Table 3.8 Effect of type of staff in charge (Pharmacist’s Assistant versus Nurse)
on Drug Supply Management Indicators
Indicator
Staff in charge of DSM
p valuePA, n = 7 Nurse, n = 29
No % No %
Restricted access 2 28.6 14 48.3 0.6045
All stock off the floor 5 71.4 17 58.6 0.8485
Adequate receiving procedures 1 14.3 19 65.5 0.9521
Has all SOPs 0 0.0 17 58.6 0.0180
Use formal quantification method 6 85.7 13 44.8 0.1277
Use stock cards 0 0 24 82.8 0.0002
Av. %items stock on card = shelf - - - 57.8 -
Record fridge temperature daily 7 100.0 21 80.8* 0.5056
No stock in fridge door 5 71.4 22 84.6* 0.8019
No food/drink in vaccine fridge 7 100 23 88.5* 0.8399
Av. % o f items O/S at least once - 22.9 - 36.2 0.1826
Av. % in stock on day o f study - 90.1 - 86.9 0.4288
SOPs = Standard Operating Procedures, Av = Average, PA = Pharmacist’s Assistant, 
DSM = Drug Supply Management, O/S = Out o f stock, *n=26
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The indicators o f the two categories were as follows: -
• Only 28.6% o f the clinics run by a Pharmacist’s Assistant controlled access to the 
drug store, compared to 48.3% run by a nurse.
• All stock was off the floor at 71.4% o f the clinics run by Pharmacist’s Assistants, 
compared to 58.6% run by nurses.
• Receiving procedures were adequate at 14.3% o f the clinics run by a Pharmacist’s 
Assistant, compared to 65.5% run by a nurse.
• There was no clinic run by a Pharmacist’s Assistant that had the entire tracer 
Standard Operating Procedures compared to 58.6% o f the clinics run by a nurse.
• The majority (85.7%) o f the clinics run by a Pharmacist’s Assistant used a formal 
quantification method, compared to 44.8% o f the clinics run by a nurse.
• None o f the clinics ran by a Pharmacist’s Assistant had a standard stock card, 
compared to 82.8% o f the clinics run by a nurse.
• At all the clinics run by a Pharmacist’s Assistant the fridge temperature was 
monitored daily, compared to 80.8% o f the clinics run by a nurse.
• No stock was found in the fridge door at 71.4% o f the clinics run by a 
Pharmacist’s Assistant, and at 84.6% o f those run by a nurse.
• No food or drink was found in the vaccine fridge at all clinics run by a Pharmacist 
Assistant, and at 88.5% o f those run by a nurse.
3.3.2. Effect of Rotation of Staff In-charge on Drug Supply Management 
Indicators
Table 3.9 (page 35) shows that the number o f clinics at which the staff in charge o f
the Drug Supply Management was rotated was equal to that where the staff in-charge
was permanent.
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Table 3.9 Effect of Rotation of Staff In-charge on Drug Supply Management
Indicators
Indicator
Nature of Deployment
p valuePermanent, n=18 Rotation, n = 18
No % No %
Restricted access 10 55.6 6 33.3 0.3143
All stock off the floor 10 55.6 12 66.7 0.7324
Adequate receiving procedures 12 66.7 8 44.4 0.3143
Has all SOPs 9 50.0 8 44.4 0.6318
Use formal quantification method 9 50.0 10 55.6 0.3682
Use stock cards 13 72.2 11 61.1 0.7237
Av. %items stock on card = shelf - 61.6 - 50.5 0.3492
Record fridge temperature daily 12 80.0** 16 88.9 0.8246
No stock in fridge door 13 86.7** 14 77.8 0.8368
No food/drink in vaccine fridge 12 80.0** 18 100 0.1670
Av. % o f items O/S at least once - 35.1 - 31.7 0.6948
Av. % in stock on day o f study - 86.2 - 88.7 0.4549
SOPs = Standard Operating Procedures, Av = Average, **n=15, O/S = Out o f stock
The indicators o f the two categories were as follows: -
• Access to the drug store was controlled at 33.3% o f the clinics where the in­
charge was rotated, compared to 55.6% where the in-charge was permanent.
• All the stock was off the floor at 66.7% o f the clinics where the in-charge was
rotated compared to 55.6% where the in-charge was permanent.
• Receiving procedures were adequate at 44.4% o f the clinics where the in-charge 
was rotated, compared to 66.7% where the in-charge was permanent.
• A formal quantification method was used at 55.6% o f the clinics where the in­
charge was rotated, compared to 50% where the in-charge was permanent.
• Standard stock cards were used at 61.1% o f the clinics where the in-charge was 
rotated, compared to 72.2% where the in-charge was permanent.
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The fridge temperature was recorded daily at 88.9% of the clinics where the in­
charge was rotated, compared to 80% where the in-charge was permanent.
3.3.3. Impact of Training in Drug Supply Management
Table 3.10 below (derived from Table A6 [page 72] and Table A8 [pages 74-79]) 
shows that thirty clinics had at least one staff trained in Drug Supply Management 
while four clinics had none. Data on training in Drug Supply Management at two 
clinics was not available as there was no record.
Table 3.10 Impact of Training in Drug Supply Management
Indicator
Number of staff trained in DSM
p valueAt least one, n = 30 None, n = 4
No % No %
Restricted access 13 43.3 2 50.0 0.7766
All stock off the floor 19 63.3 2 50.0 0.9743
Adequate receiving procedures 19 63.3 1 25.0 0.3563
Has all SOPs 3 10.0 1 25.0 0.9612
Use formal quantification method 16 53.3 1 25.0 0.5945
Use stock cards 22 73.3 2 50.0 0.7055
Av. %items stock on card = shelf - 57.6 - 37.5 0.3390
Record fridge temperature daily 23 85.2*** 3 75.0 0.8325
No stock in fridge door 23 85.2*** 3 75.0 0.8325
No food/drink in vaccine fridge 24 gg q*** 4 100 0.8379
Av. % o f items O/S at least once - 33.0 - 50.9 0.3026
Av. % in stock on day o f study - 86.8 - 95.6 0.0683
SOPs = Standard Operating Procedures, Av = Average, **n=15, O/S = Out o f stock,
DSM = Drug Supply Management
The indicators o f the two categories were as follows: -
• Access to the drug store was controlled at 43.3% o f the clinics where at least one 
staff was trained, compared to 50% where no staff was trained.
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• All the stock was off the floor at 63.3% of the clinics where at least one staff was
trained compared to 50% o f the clinics where no staff was trained.
• Receiving procedures were adequate at 63.3% o f the clinics where at least one 
staff was trained compared to 25% where no staff was trained.
• The entire tracer Standard Operating Procedures were available at 10% o f the 
clinics where at least one staff was trained, compared to 25% where no staff was 
trained.
• A formal quantification method was used at 53.3% o f the clinics where at least 
one staff was trained, compared to 25% where no staff was trained.
• Standard stock cards were used at 73.3% o f the clinics where at least one staff was 
trained, compared to 50% where no staff was trained.
3.3.4. Impact of Training in Rational Drug Use 
Training in Rational Drug Use is more likely to influence prescription and patient care 
indicators. Table 3.11 (derived from Table A8 page 74-79) below shows indicators of 
a group o f clinics with at least one person trained in Rational Drug Use and the other 
group with nobody trained in Rational Drug Use.
Table 3.11 Impact of training in Rational Drug Use on some Drug Supply
Management Indicators
Number of staff trained in
Rational Drug Use
Indicator
At least one None
Target p value
n = 26 n = 5
Average Number of Drugs per Patient 2.22 2.51 <2 0.2799
Av.% Drugs Prescribed by Generic name 52.3 51.6 100 0.9412
Av. % of Encounters given an Antibiotic 35.9 30.2 <25 0.4778
Av. % of Encounters given an Injection 17.7 9.4 <15 0.0099
Av. % Prescribed drugs on the EDL 95.6 95.7 100 0.9664
Av. = Average, EDL = Essential Drug List
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The average number o f drugs per patient encounter among clinics with at least one 
person trained was 2.22 compared to 2.51 in the group with nobody trained. Generic 
names were used in 52.3% o f all the prescribed drugs among the group with trained 
personnel compared to 51.6% among the group with nobody trained. On average, 
35.9% o f the patient encounters among clinics with at least one trained person 
received an antibiotic compared to 30.2% in the group with no one trained. On 
average, 17.7% o f the patient encounters in the group with at least one trained person 
received an injection compared to 9.4% among the group with no one trained. On 
average, 95.6% o f the drugs prescribed at the clinics with at least one trained person 
were on the Essential Drugs List for Primary Health Care facilities compared to 
95.7% at the clinics with no one trained.
3.3.5. Impact of Training in Cold Chain Management 
Table 3.12 below (derived from Table A8 page 74-79) shows the indicators o f the 
twenty-five clinics with at least one person trained in Cold Chain Management and 
six with nobody trained.
Table 3.12 Variation of Indicators According to number of Personnel Trained in
Cold Chain Management
Indicator Affected
Number Trained in Cold Chain 
Management
p valueAt least one 
(n=25) None (n=6)
No % No %
Record fridge temperature daily 22 88.0 5 83.3 0.08544
No stock in fridge door 22 88.0 5 83.3 0.08544
No food/drink in vaccine fridge 22 88.0 6 100 0.37346
The clinics with at least one person trained in Cold Chain Management performed 
better in recording the fridge temperature and avoiding storage o f stock in the fridge 
door compared to those with no one trained. No food or drink was found in the fridge
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at all the clinics with no one trained compared to 88% o f those with at least one 
person trained.
3.3.6. Effect of the Method of Quantification on Availability of Drugs
An adequate quantification method is expected to enhance drug availability at the 
facility. Table 3.13 below (derived from Table A7, page 73) shows drug availability 
indicators according to the method o f quantification and their correlation with the 
percentage o f tracer items whose re-order level had been determined (%ROL).
On average, 23.7% o f the tracer items had been out o f stock at least once in the past 
year among clinics with a good quantification method compared to 43.8% at the 
clinics without a good quantification method. Among the clinics with a good 
quantification method, 88.2% o f the tracer items were in stock on the day o f the study 
compared to 86.6% at the clinics that used only experience.
Table 3.13 The Impact of Quantification Method on Drug Availability
Indicators.
Quantification Method r of %ROL
Indicator ROL/Min-
Max
Experience
p value
versus
availability
indicator
% o f tracer items O/S in the past year 23.7 43.8 0.0138 r = -0.299
% of tracer items in stock on day o f study 88.2 86.2 0.6778 r = +0.104
r = Correlation coefficient, ROL =Re-Order Level, Min-Max = Minimum- Maximum 
Levels, %ROL = % o f items whose ROL had been determined
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3.3.7. Effect of Supply from Independent Sub-depot or Hospital
Pharmacy on Some Drug Supply Management indicators
The drug supply indicators for the two categories o f suppliers are presented in Table 
3.14 below (derived from Table A4, page 70).
Table 3.14 Drug Supply Indicators at the Clinic According to Type of Supplier
Type of supplier
Lead time 
(days)
% of order 
supplied
% O/S in past 
year
% in stock on 
study day
Average for all Sub-depots 11.2 79.0 33.1 87.6
Independent sub-depots 11.7 82.5 24.6 88.8
Hospital pharmacies 10.3 70.9 50.0 85.0
p values 0.4521 0.0069 0.0024 0.2813
O/S = Out o f stock
Independent Sub-depots and Hospital Pharmacies had practically similar lead times 
but the former had a better service level. Clinics supplied by independent Sub-depots 
had better availability and less stock out o f key drugs compared to those supplied by 
Hospital Pharmacies.
3.3.8. Effect of Availability of Standard Operating Procedures on Status 
of Drug Supply Management
Table 3.15 below shows indicators according to availability o f standard operating 
procedures.
Table 3.15 Distribution of clinics and variation of Indicators According to
Availability of Standard Operating Procedures
Receiving
adeq
Procedures
uate
Stock Off the 
floor
Good Quantification 
Method
% ROL 
determined
Yes No Yes No Yes No Average
Has all SOPs 12 5 12 5 8 9 66.5
No SOPs 8 11 10 9 11 8 81.3
p values 0.1673 0.4467 0.7522 0.5098
ROL Re-Order Level
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In the next chapter, the above results are discussed in comparison with standard 
performance targets and results from other studies carried out in South Africa and 
other countries.
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4. DISCUSSION
4.1.Status of Drug Supply Management
4.1.1. Facility Indicators
The status o f facilities has an impact on the quality o f Drug Supply Management. 
Table 3.2 (page 25) shows that the proportion o f clinics with adequate storage 
facilities was generally low, although clinics under City o f Tshwane Metropolitan 
Municipality had generally better facility indicators than those under Gauteng 
Provincial Authority, Moretele and Odi Districts. The status o f facilities for Drug 
Supply Management was similar to what was observed by Summers et al in NMTTS 
District o f Northern Province .
4.1.2. Performance of the Main Suppliers of Primary Health Care 
Clinics in Tshwane
Table 3.3 (page 26) shows that all the sub-depots received a good service level 
(>94%) from the provincial depots compared to the WHO recommended standard 
(95%). However, their average service level (79%) to the Primary Health Care clinics 
was below this standard performance target. Only a few clinics (4%) received a level 
o f service above the standard. Nevertheless, this service level was better than what 
was observed in NMTTS District o f Northern Province (66.7%)32.
Table 3.14 (page 40) shows that clinics supplied by independent sub-depots (Pretoria 
Regional Pharmacy and Tshwane Metro Pharmacy) had better drug availability and 
less out o f stock o f tracer items compared to those supplied by hospital pharmacies 
(Jubilee and Odi). The differences between the two groups were significant with 
respect to average service level (p = 0.0069) and average percentage o f items that had 
been out o f stock at least once in the past year (p = 0.0024), but the data could not
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prove the difference with respect to average lead time (p = 0.452) and percentage o f 
tracer items in stock on the day o f the study (p = 0.281).
This data shows that drugs were less likely to be out o f stock and hence more 
available at clinics supplied by an independent sub-depot compared to those supplied 
by a hospital pharmacy. It is likely that a hospital pharmacy gave priority to the 
hospital in case o f drug shortage thus causing shortages at the clinics supplied.
Stafford et a f  did not perform this assessment during the pharmaceutical audit in 
Tshwane.
4.1.3. Procurement, Availability and Control of Drugs
4.1.3.1. Availability of Standard Operating Procedures
Availability and use o f standard operating procedures ensures consistency in carrying 
out operations. All clinics were expected to have all the tracer standard operating 
procedures but only 47% o f the clinics had all o f them (Table 3.15, page 40). 
However, the differences between indicators o f the group o f clinics with standard 
operating procedures and the group without were not statistically significant (p>0.05). 
This confirms the observation that in most cases where the standard operating 
procedures were available, they were filed away and not available to the staff 
performing the duties.
4.1.3.2. Receiving Procedures
The standard way to receive stock is for received stock to be off-loaded in a secure 
cage where it is quarantined and checked against the order, invoice and delivery note 
before placing it in the main store. The delivery note should be in duplicate and both 
parties must retain a signed copy. Any discrepancies should be formally reported 
within a stipulated period40. These measures are meant to enhance control o f and 
accountability for drugs throughout the supply chain. This was practised at only 56%
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o f the clinics. This points to poor accountability for drugs since one cannot account 
for drugs for which there is no confirmation o f receipt.
4.1.3.3.Availability and Use of Stock Cards.
A Stock card is an important tool for drug management. According to Gray41, stock 
cards serve four basic functions:
• They allow staff to account for and monitor the movement o f drugs over a period 
o f time. By comparing physical stock with record o f stock balance on the card 
(stocktaking) one is able to identify stock losses or disappearance o f drugs.
• They are used to calculate the quantities o f drugs that need to be ordered. If 
correctly maintained, one is able to calculate consumption and hence quantities to 
order.
• They can be used to monitor the efficiency o f the Drug Management System. If 
well maintained, one can calculate Lead Time, Ordering Frequency and stock out 
levels from stock cards.
• They aid proper storage o f drugs and stock rotation by alerting staff to the expiry 
dates.
For effective drug control, there should be one stock card per item. A separate stock 
card is created for each item, in each pack size and strength. The necessary 
information must be recorded at the time o f each stock movement (receipts, issues and 
write-offs)41.
The maintenance o f stock cards was studied using the tracer drugs and non-drug 
items. Out o f 36 facilities evaluated, 24 (67%) used stock cards (Table 3.4, page 27). 
On average physical stock on the shelf was found to be equal to the balance quantities 
on the stock card only for 55.9% (range 8.3% to 100%) o f the tracer items, compared
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to the performance standard o f 100%. Errors in management o f stock cards arose 
because o f reasons similar to those identified by Gray 41:
• Stores were disorganised so that stock could not be linked to the correct card.
• “Closed” stock was accessible without restrictions.
• Stocktaking was not done and discrepancies not traced and corrected.
• Stock was received or issued but not recorded.
• No one was made responsible for stock management.
• Personnel were not well trained.
• Different facilities used different systems making monitoring difficult.
• Stock cards were poorly designed or did not record all the information needed. 
The availability o f stock cards was better than what was observed earlier in Tshwane 
by Stafford et al (47%)8 in 2000, and in Northern Province by Summers et al, 
(42.9%)32. Balancing o f stock was more accurate than what Stafford et al found 
earlier (41%)8, but less accurate than what Summers et al found in Northern Province 
(95%)32. This further points to poor control and accountability for drugs.
4.1.3.4.Quantification Method
A good quantification method is important to avoid stock-outs and ensure continuous 
availability o f essential drugs and supplies; to avoid wastage due to overstocking; to 
make the best use o f scarce resources, and; to provide accurate data to lobby for 
adequate funding.
All clinics were therefore expected to have a formal quantification method to 
determine the quantities o f  drugs to order. During this study, both the Re-Order Level 
(ROL) and Minimum-Maximum Level (Min-Max) methods were considered 
adequate, but use o f only experience was not considered adequate. Therefore, the Re- 
Order Levels o f all tracer items were expected to have been determined.
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Table 3.4 (page 27) shows that the method o f quantification was found adequate at 
53% o f the clinics. This was worse than what was found earlier (88%)8, but better 
than what was observed in Northern Province (0%)32. On average, the Re-Order 
Levels o f  only 33.8% o f the tracer items had been determined, compared to the 
standard target o f 100%. It is possible that poor quantification methods may have 
contributed to the dispute over the actual drug budget requirements and the observed 
stock outs.
4.1.3.5.Availability of Tracer Drugs
Drug availability is the litmus test for the status o f Drug Supply Management. Table 
3.4 (page 27) shows that on average 33.1% (range 0% to 83.3%) o f the tracer items 
had been out o f stock at least once in the past year, compared to the standard o f <10%. 
Only 7% o f the clinics met this standard. On the day o f the study, on average 87.6% 
(range 70% to 100%) o f the tracer item were in stock, compared to the standard target 
o f  90%. Slightly more than half (58%) o f the clinics met the target. Drug availability 
was similar to what was observed in Kampong Thom Province in Cambodia 
(86.6%)23, but better than what was observed in NMTTS District o f Northern 
Province (75.2%)32. Data obtained by Stafford et al8 could not be compared because 
different indicators were used. Nevertheless, these results point to weaknesses in Drug 
Supply Management in Tshwane.
4.1.4. Cold Chain Management Indicators 
The ideal way to maintain a vaccine cold chain is to use a standard Expanded 
Programme for Immunisation fridge, record the fridge temperature daily using a 
Minimum-Maximum thermometer, avoid keeping stock in the fridge door and avoid 
using the vaccine fridge to store food and drinks11,42. The cold chain indicators are 
presented in table 3.6 (page 31). These observations show that cold chain
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management was generally adequate, although there was great variation between the 
clinics. The majority o f  the clinics (92%) had a fridge, although only 35% (12 out of 
34) o f the fridges were o f  the Expanded Programme for Immunisation standard type. 
Most o f  these clinics (85%) complied with the standard o f recording the fridge 
temperature daily, though only a few (45%) used the ideal Minimum-Maximum 
thermometer. Other clinics used a normal thermometer and recorded the fridge 
temperature twice daily to try and capture the coolest and hottest parts o f  the day. This 
practice has limitations given the fluctuation o f weather in Gauteng. Some incidences 
o f  poor practice were found; stock was found stored in the fridge door in six (18%) of 
the clinics with a fridge and food or drinks were found stored in the vaccine fridge in 
three (9%) the clinics. The level o f  cold chain management was comparable to that 
observed by Summers et al in Northern Province32 and Gazmararrian el al at primary 
care offices in four cities in USA25.
4.1.5. Prescribing Indicators
Table 3.7 (page 32) shows that prescribing was generally below the performance 
targets. Only 13 clinics (39%) scored within the performance target o f not more than 
an average o f 2 drugs per patient encounter. The average number o f drugs per patient 
encounter was 2.27 (range o f 1.57 to 3.67). This is similar to what was observed by 
Stafford et al (2 .43)8 in Tshwane, but higher than what was observed by Summer et 
al (1.85) in NMTTS District o f Northern Province32. It is also similar to what was 
observed in Mozambique (2.2)11, Tanzania (2.2)27 and Cambodia (2.35)23, but lower 
than what was found in Indonesia (3.3)14, Swaziland (3.0)11, Cameroon (3.0)11, 
Nigeria (3.8)15, and Ghana (4.3) n .
None o f the clinics had all the drugs prescribed by generic name, as recommended. 
On average, 51.6% (range 12.5% to 98.0%) o f the drugs were prescribed by generic
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name. This is below what was observed in Northern Province (60.4) 32 and most 
studies cited earlier from other countries12 (Table 1.2, page 8), except Nepal (44%)28 
and Ecuador (37%)29.
On average 35% (range 0% to 65.5%) o f all patient encounters received at least one 
antibiotic. This is higher than the target upper limit o f 25% patient encounters, but 
similar to what was observed in Northern Province (37.8%)32 and Malawi (34%)13. 
The use o f antibiotics was higher in most o f the other studies earlier cited12 (Table
1.2, page 8). Nevertheless, 75% o f the clinics were within the target o f not more than 
25%.
On average, 17.2% (range 0% to 46.7%) o f all patient encounters received an 
injection. This was slightly higher than the target upper limit o f 15% patient 
encounters, and higher than what was observed in Northern Province (9.8%) . It is 
similar to what was observed in Malawi (19%)13, Indonesia (17%)14, Mozambique 
(18% )" and Ecuador (17%)29, but lower than what was observed in Uganda (36%)26, 
Sudan (36%)17, Swaziland (38%)11, Tanzania (29%)27, Nigeria (37%)15, Ghana 
(56% )" and Cameroon (41%)n . Less than a half (42%) o f the clinics were within the 
target o f  not more than 15%.
Although the average percentage o f drugs prescribed that were on the Essential Drug 
List for Primary Health Care Facilities (95.6%) was below the 100% target43, it was 
higher than what was observed in Northern Province (83.9%)32, Tanzania (88%)27 and 
Nepal (86%)28. It is however similar to what was observed in Cambodia (99.7%)23. 
Only 24% o f the clinics met the target o f 100%.
Although the prescription indicators for most clinics were below the performance 
target the overall performance was reasonable. Nevertheless, the use o f antibiotics 
was high and needs further investigation.
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4.2.Evaluations of the Gaps Observed in Drug Supply 
Management in Tshwane
The discussion in the previous section shows that the status o f Drug Supply 
Management in Tshwane was generally inadequate compared to the WHO 
recommended performance standards. The following is an evaluation o f some o f the 
possible reasons for the observed gaps. It is based on the hypotheses set up for the 
study.
4.2.1. Effect of Quantification Method on Drug Availability
An adequate quantification method is expected to enhance drug availability at the 
facility. Table 3.13 (page 39) shows that on average, 23.7% o f the tracer items had 
been out o f stock at least once in the past year among clinics with a good 
quantification method compared to 43.8% at the clinics without a good quantification 
method. Among the clinics with a good quantification method, 88.2% o f the tracer 
items were in stock on the day o f the study compared to 86.6% at the clinics that used 
only experience. There was a slightly positive correlation between the percentages o f 
tracer items whose re-order level had been determined and both the percentage o f 
tracer items in stock on the day o f the study (r = +0.104). There was a slightly 
negative correlation between the percentage o f tracer items whose re-order level had 
been determined and the percentage o f items that had been out o f stock at least once 
in the past year (r = -0.299). The differences between the two groups were significant 
with respect to the average percentage o f items that had been out o f stock at least once 
in the past year (p = 0.01381). However, the data could not prove the difference 
between the two groups with respect to the average percentage o f tracer items in stock 
on the day o f the study (p = 0.6778).
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This data shows that determination o f the Re-Order Levels facilitated drug 
quantification, which in turn enhanced drug availability and reduced stock outs. It can 
therefore be concluded that a good quantification method was associated with better 
drug availability and less stock outs.
Stafford et al8 did not perform this assessment during the pharmaceutical audit in 
Tshwane.
4.2.2. Effect of Category of Staff (Pharmacist’s Assistant versus Nurse) 
on Drug Supply Management Indicators
Once drugs are available at the clinic and there are adequate facilities, professional 
guidelines require that drugs should be managed full time by someone with basic 
training in Pharmacy and/or further training in Drug Supply Management. Table 3.5 
(page 29) shows that staffing for Drug Supply Management was not adequate in terms 
o f appropriate cadre and nature o f deployment. Pharmacist’s Assistants (PAs) were 
in-charge o f Drug Supply Management at seven facilities (19%), all belonging to the 
City o f Tshwane, compared to twenty-nine (81%) by nurses.
Table 3.8 (page 33) shows that 28.6% o f the clinics where a Pharmacist’s Assistant 
was in charge practised restricted access to the store compared to 48.3% o f those 
where a nurse was in charge (p = 0.6045). Receiving procedures were adequate at 
14.3% o f the clinics where a Pharmacist’s Assistant was in charge compared to 65.5% 
o f those where a nurse was in charge (p = 0.9521). Although these differences were 
insignificant, they were also contrary to expectations. A possible explanation for the 
differences was that Pharmacist’s Assistants actually only used these seven clinics as 
base stations but were assigned more than one clinic. In their absence, nurses took 
charge o f Drug Supply Management, thus having unrestricted access. Often, drugs 
were delivered in the absence o f the Pharmacist’s Assistant and no one took
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responsibility for the receiving procedures because this was seen as the responsibility 
o f the Pharmacist’s Assistant.
The average percentage o f tracer items that had been out o f stock at least once in the 
past year was 22.9% in clinics where the person in charge was a Pharmacist’s 
Assistant compared to 36.2% in clinics where the person in charge was a nurse (p = 
0.1826). The average percentage o f tracer items found in stock on the day o f the study 
was 90.1% in clinics where the person in charge was a Pharmacist’s Assistant 
compared to 86.9% in clinics where the person in charge was a nurse (p = 0.4288). 
The differences too were not significant.
The only significant differences between the two groups were with respect to 
availability o f standard operating procedures (SOPs) (p = 0.0180) and use o f stock 
cards (p = 0.0002), where the clinics at which the person in charge was a nurse 
performed better. A possible explanation to these differences lies in the fact that SOPs 
and stock cards are policy documents, which are normally developed at the 
departmental level. All the clinics where the person in charge was a Pharmacist’s 
Assistant belonged to the City o f Tshwane, which had not developed these 
documents.
Therefore, the data from this study did not prove that the type o f health worker 
(Pharmacist’s Assistant versus nurse) in charge o f Drug Supply Management at the 
clinic had a significant impact on drug availability. The possible effect o f the small 
number o f  clinics where the Pharmacist’s Assistant was in charge (seven), on the level 
o f  significance should be borne in mind38. The rotation o f the Pharmacist’s Assistant 
between several clinics made them ineffective. Drug Supply Management was 
effectively in the hands o f nurses at all clinics, hence, the lack o f significant 
difference. In fact lack o f responsibility was likely to result in poor controls and lack
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o f accountability for drugs at the clinics among which the Pharmacist’s Assistants 
rotated. There is also a possibility that more factors influence the level o f Drug 
Supply Management, than the category o f health worker in charge. An assessment of 
rational drug use and prescribing in primary health care facilities in Northwest 
Ethiopia showed that, apart from a few exceptions, the drug use indicators in health 
centres and health stations and between retrospective and prospective studies were 
similar despite differences in manpower and facilities .
4.2.3. Effect of Rotation of Personnel in Charge of Drug Supply 
Management Indicators
Table 3.5 (page 29) shows that the clinics at which the person in charge o f Drug 
Supply Management was permanent were equal in number to those where the person 
in charge was rotated.
Table 3.9 (page 35) shows that clinics with a permanent person in charge had better 
indicators for practising restricted access to the store, receiving procedures, 
availability o f  SOPs and use o f stock cards, compared to those where the person in 
charge was rotated. This further clarifies the observations at clinics where the 
Pharmacist’s Assistants were in charge but rotated among several clinics. 
Nevertheless, the differences between the indicators for the two groups were not 
significant (p > 0.05).
Also differences in drugs availability were noted between the groups. Also the 
differences between the two groups were found not to be significant for percentage of 
tracer items that had been out o f stock at least once in the past year (p = 0.6948); 
percentage o f tracer items that were found in stock on the day o f the study (p = 
0.4549), and; the percentage o f tracer items whose physical stock was equal to the 
balance as shown on the card (p = 0.3492).
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Therefore, although a permanent person in charge was associated with better Drug 
Supply Management indicators, the data did not prove that rotation o f the person in 
charge had a significant impact on the status o f  Drug Supply Management.
4.2.4. Effect of Training in Drug Supply Management on the Status of 
Drug Supply management
Professional guidelines require that drugs should be managed full time by someone 
with basic training in Pharmacy and/or further training in Drug Supply Management. 
This implies that clinics that have at least one person trained in Drug Supply 
Management are expected to manage drugs better.
Table 3.5 (page 29) shows that the majority (30 out o f 34) o f the clinics evaluated had 
at least one staff trained in Drug Supply Management. Table 3.10 (page 36) shows 
that this group had better indicators for keeping stock off the floor, adequate receiving 
procedures, good quantification method, use o f stock cards and balance o f physical 
stock with record on the card. However, the differences were found not to be 
significant (p > 0.05).
The small sample in the comparison group (4 clinics without anybody trained) could
•  •  t ohave contributed to this unexpected observation . In addition, the study observed 
that, in most cases, the skills acquired from the training were not passed on to other 
staff and the person trained was not always the one in charge o f Drug Supply 
Management. The study also observed that health managers did not effectively 
supervise the personnel in charge o f drugs at most o f the clinics. Under such 
circumstances, any improvements could not be sustained. This view is supported by 
the observations by Trap et al, in a randomised controlled indicator study in 
Zimbabwe, to assess the impact o f supervision on stock management and adherence 
to treatment guidelines . It was observed that, while training o f health workers
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throughout the country in drug management (including stock management and 
rational drug use) resulted in significant improvements in a variety o f drug supply 
management indicators; these achievements could not be sustained until a further 
intervention o f support supervision was introduced.
Therefore, the skills acquired from training were not properly deployed to influence 
quality Drug Supply Management.
4.2.5. Effect of Training in Rational Drug Use on the Status of Drug 
Supply Management
Training in Rational Drug Use is more likely to influence prescription indicators. 
Table 3.11 (page 37) shows that the clinics with at least one person trained in Rational 
Drug Use performed better with respect to the number o f drugs per patient encounter 
(p = 0.2799), use o f generic names (p = 0.9412) and percentage o f patient encounters 
with an antibiotic prescribed (p = 0.4778) compared to the clinics with nobody 
trained. On the other hand, the clinics with at least one person trained in Rational 
Drug Use performed worse with respect to the percentage o f patient encounters with 
an injection prescribed (p = 0.0099) and the percentage o f drugs prescribed that was 
on the Essential Drug List for Primary Health Care facilities (0.9664) compared to the 
Clinics with no one trained. However, only the difference between the percentages of 
encounters that received an injection was significant. Otherwise, training in Rational 
Drug Use seemed to have had no significant impact on prescribing indicators. This is 
similar to what Mallet et al observed in their evaluation o f prescription practices and 
the rational use o f medicines, as part o f evaluating an essential drugs and costs 
recovery program in Niger24. It was observed that training nurses in using National 
Standard Treatment Guidelines seemed to have a limited impact on their prescribing 
patterns.
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Various factors influence the magnitude o f impact o f  Rational Drug Use training. 
These include the content o f the training and support supervision, among others. 
Health Systems Trust observed that the content o f the Rational Drug Use Training 
Project in South Africa was limited and was not a solution in itself, particularly if 
there was no continuous support supervision44. This observation is consistent with the 
findings o f Kafuko et al2b and Trap et al22 who concluded that availability o f Standard 
Treatment Guidelines and training without effective support supervision will not lead 
to sustained improvements in drug use.
The personnel in the clinics evaluated were trained under the Rational Drug Use 
Project referred to above and support supervision in the clinics studied was 
inadequate. These factors may be responsible for lack o f significant differences 
between the indicators o f the two groups. The possible effect o f the small number of 
clinics with no one trained in Rational Drug Use (five), on the level o f significance
T O
should also be borne in mind .
4.2.6. Effect of Training in Cold Chain Management
Table 3.12 (page 38) shows that the clinics with at least one person trained in Cold 
Chain Management had better indicators in recording the fridge temperature (p =
0.08544) and avoiding storage o f stock in the fridge door (p = 0.08544) compared to 
those with no one trained. No food or drink was found in the fridge at 100% o f the 
clinics with no one trained compared to 88% o f those with at least one person trained 
(p = 0.37346).
However, the differences between the two groups were found not to be significant (p 
> 0.05). This data did not show that training had a significant impact on Cold Chain 
Management indicators in Tshwane. The possible effect o f the small number of 
clinics with no one trained in Cold Chain Management (six), on the level o f
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significance should also be borne in mind38. Gazmararian et al observed that several 
factors influenced compliance o f primary care physician offices, in four cities in USA, 
with vaccine storage guidelines . Practice location, type o f physician, participation in 
vaccine programmes, and using guidelines were associated with compliance. 
Therefore, factors beyond training may have influenced the level o f cold chain 
management in Tshwane.
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5. CONCLUSION
The results o f a situation analysis into Drug Supply management in Tshwane show 
that Drug Supply Management was generally below the WHO recommended 
performance indicators1,11. It was below what Stafford et al observed in 20008, but 
better than what Summers et al observed in NMTTS District o f Northern Province . 
The status was comparable with, and in some instances better than, what was 
observed in other countries11,12,17. Inadequate control o f and accountability for drugs 
at all levels was the main shortcoming observed.
The study proved that in Tshwane, the type o f staff, staff training and rotation o f the 
staff in charge o f Drug Supply Management did not have a significant impact on the 
status o f Drug Supply Management. The main reasons for this observation were that 
there was no one given full time responsibility for Drug Supply Management. The 
trained personnel were neither appropriately deployed nor effectively supervised and 
there was no effective cascading o f information after training. The adequacy o f the 
content o f  some o f the training received by the staff was questionable, according to 
the literature surveyed41. The possible effect o f the small sample size in some o f the 
comparison groups, on the level o f significance should also be borne in mind when
1  o
interpreting the p values .
Availability o f  standard operating procedures was not associated with better Drug 
Supply Management. This was due to the fact that in most cases where the standard 
operating procedures were available, they were filed away and not available to the 
staff performing the duties. However, a formal quantification method was associated 
with better availability and less drug stock out incidences. Clinics supplied by 
independent Sub-depots received a better service level and had less stock out 
incidences o f key drugs compared with those supplied by Hospital Pharmacies.
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6. RECOMMENDATIONS
There is need to improve accountability for and control o f drugs and consequently
improving the status o f Drug Supply Management in Tshwane by:
• ensuring that there is someone at each clinic with full-time responsibility for Drug 
Supply Management, who should be effectively trained, appropriately deployed 
and well supervised. This will ensure focused attention to all Drug Supply 
Management issues
• ensuring that all clinics are supplied from an independent Sub-depot, as opposed 
to a hospital pharmacy. Consideration should be made to merge operations o f 
Pretoria Regional Pharmacy and the City o f Tshwane Sub-depot in order to 
eliminate duplication and improve efficiency through cost-effective use o f 
available resources
• ensuring all clinics have and use standard operating procedures. This will 
standardise operations thereby facilitating control o f and accountability for drugs
• ensuring that all clinics adopt a formal method o f quantifying drugs. This will 
facilitate budgeting for drugs, improve drug availability and reduce drug stock 
outs
• increasing accountability for drugs up to the dispensing level by promoting, and 
training staff in, the use o f stock cards
• improving information flow about the budget plus the budgeting process and 
encouraging use o f  the budget when ordering drugs.
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APPENDIX A; TABLES OF RESULTS
Table A1 Distribution of Patient Encounters in the Evaluated Clinics
Facility Type Owner Prospective Retrospective Total Encounters
Atteridgeville Clinic CTMM 22 30 52
Danville Clinic CTMM 12 28 40
Folang Clinic CTMM 23 30 53
Gazankulu Clinic CTMM - 26 26
Hercules Clinic CTMM 7 30 37
Karenpark Clinic CTMM - 30 30
Laudium Clinic CTMM - 30 30
Lyttelton Clinic CTMM - - 0
Mamelodi West Clinic CTMM 30 25 55
Phahameng Clinic CTMM 30 30 60
Phomolong Clinic CTMM 26 30 56
Rosslyn Clinic CTMM - 30 30
Silverton Clinic CTMM 22 30 52
Stanza Bopape 2 Clinic CTMM 30 - 30
Laudium CHC GPA - 27 27
Soshanguve 3 CHC GPA - 30 30
Stanza Bopape CHC GPA - 30 30
Boikhutsong Clinic GPA - 29 29
Bophelong Clinic GPA 30 30 60
Eesterust Clinic GPA 2 20 22
Mandisa Shiceka Clinic GPA 30 1 31
Pretoria North Clinic GPA 11 29 40
Skinner Street Clinic GPA - 30 30
Soshanguve JJ Clinic GPA - 30 30
Sedibeng HC Clinic GPA 15 30 45
Refentse CHC Moretele 7 30 37
Temba CHC Moretele - 30 30
Jubilee Gateway Clinic Moretele - 30 30
New Eersterust Clinic Moretele - 30 30
Ramotse Clinic Moretele 24 30 54
Suurman Clinic Moretele - 30 30
Boekenhout CHC ODI - 30 30
Kgabo CHC OD1 - 30 30
Phedison I CHC ODI - 30 30
Itireleng Clinic ODI - 30 30
Mpho ya Batho Clinic ODI - 30 30
TOTAL 321 965 1286
CTMM = City of Tshwane Metropolitan Municipality, GPA = Gauteng Provincial Authority,
CHC = Community Health Centre
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Table A2 Facility Indicators for Primary Health Care Facilities in Tshwane
BOIKHUTSONG X V V V V N/A V V V X V V V
BOPHELONG X X V V V N/A V V a/ X X V X
EESTERUST X X a/ X X V a/ V V X X X X
LAUDIUM V X X V V V V V V X X X
MAND1SA SHICEKA X V V V V X X V V X V V X
PRETORIA NORTH X X V V X X V V V X X V X
SKINNER STREET X X V V V V V V V X X V X
SOSHANGUVE 3 X X a/ V V X V V V X V V X
SOSHANGUVE JJ X X X X X N/A X V X X V X X
STANZA BOPAPE X X X V V N/A V V V X V V X
SEDIBENG HC X X X V V X N/A V V X V V X
JUBILEE GATEWAY X X X X X N/A No V X X V X X
NEW EERSTERUST X X X X X N/A N/A X X X V X X
RAMOTSE X X X X N/A N/A V X X X X X
REFENTSE X X X X N/A V V X X X X X
SUURMAN X X X X V N/A V X X X V V X
TEMBA X V V X V N/A V V X X V X X
BOEKENHOUT X X X X X X N/A V X X V X X
ITIRELENG X X X X X N/A N/A V a/ X V X X
KGABO X V V X X N/A V V V X V X X
MPHO YA BATHO X X X X X N/A N/A V X X X X X
PHEDISON I X V X X X N/A a/ V X X V X X
ATTERIDGEVILLE X V X V V N/A N/A V V V X V X
DANVILLE X X X V V N/A V V X X X V X
FOLANG X X V V V N/A N/A V X V V V X
GAZANKULU X X a/ X X N/A N/A V X X X V X
HERCULES V V X V a/ X V V X X X V X
KARENPARK X V X X V X N/A V V V V V V
LAUDIUM X V V V V N/A N/A V V X X V X
LYTTELTON X V X V V X V V V V V V V
MAMELODI WEST X V X V V N/A V V X X V V X
PHAHAMF.NG X X X V a/ X V a/ X X V V X
PHOMOLONG V V V V V N/A V V X X V V X
ROSSLYN X V V X V N/A N/A V V V V V X
SILVERTON X V V V X X V V X X X V V
STANZA BOPAPE 2 X V X V V X V V X X V V X
TOTAL No 3
15 16 20 23 3 21 34 17 5 22 24 4
% 8.3 41.7 44.4 55.6 63.9 8.3 58.3 94.4 47.2 13.8 61.1 66.7 11.1
V = YES, X = NO, N/A = Not app icable, CTMM = City 
GPA = Gauteng Provincial Authority, CHC
of Tshwane Metropolitan Municipa 
: Community Health Centre
ity,
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Table A3 Indicators for Drug Procurement, Availability and Control
No F a c i l i ty T y p e O w n e r
H a s
all
S O P s
R e c e iv in g
p r o c e d u r e s
L e a d
T im e
(d a y s )
%
O r d e r
S u p p l ie d
O r d e r in g
In terv a l
(d a y s )
% 0 / S
in
y e a r
Q u a n t .
M e th o d
%  h a s  
R O L
%  in 
S to c k
U se
s to c k
c a r d s
%
C a r d = S h e l f
1 Boikhutsong Clinic GPA Yes Adequate - - - - Max-Min 0.0 82.4 Yes 61.1
2 Bophelong Clinic GPA Yes Inadequate 3.4 90.0 40.5 20.0 ROL 50.0 81.0 Yes 54.5
3 Eesterust Clinic GPA No Adequate 14.1 82.1 52.6 39.1 Experience 0.0 95.7 No 46.2
4 Laudium CHC GPA Yes Adequate 7.0 78.8 51.3 12.5 ROL 100.0 90.6 Yes 28.1
5 Mandisa Shiceka Clinic GPA No Adequate 9.1 77.2 16.5 11.1 ROL 88.9 92.6 Yes 55.6
6 Pretoria North Clinic GPA No Adequate 3.7 86.5 20.0 0.0 Experience 0.0 89.5 Yes 26.3
7 Skinner Street Clinic GPA No Adequate - - - - ROL - - Yes -
8 Soshanguve 3 CHC GPA Yes Inadequate 10.6 - 36.2 26.3 ROL 63.2 94.7 Yes 31.6
9 Soshanguve JJ Clinic GPA No Inadequate - - - - Experience - - Yes -
10 Stanza Bopape CHC GPA Yes Inadequate 9.5 83.8 34.3 0.0 ROL 87.5 93.8 Yes 62.5
11 Sedibeng HC Clinic GPA No Adequate 3.6 97.7 83.2 59.1 Experience 0.0 78.3 Yes 100.0
12 Jubilee Gateway Clinic Moretele Yes Inadequate 17.1 - 39.4 83.3 Experience 0.0 83.3 Yes 54.5
13 New Eersterust Clinic Moretele No Inadequate 9.3 - 52.8 40.9 Experience 0.0 90.9 Yes 66.7
14 Ramotse Clinic Moretele No Inadequate 15.8 - 62.2 33.3 Experience 0.0 70.8 Yes 85.7
15 Refentse CHC Moretele Yes Adequate 9.8 86.7 58.4 46.2 Experience 0.0 88.0 Yes 64.0
16 Suurman Clinic Moretele Yes Adequate 9.3 74.7 57.2 70.0 Experience 60.0 75.0 Yes 90.9
17 Temba CHC Moretele Yes Adequate 11.4 70.1 45.3 73.9 Experience 43.5 91.3 Yes 87.0
18 Boekenhout CHC Odi Yes Adequate 7.5 61.9 37.3 42.9 Experience 0.0 90.0 Yes 16.7
19 Itireleng Clinic Odi No Inadequate 12.6 57.9 57.7 - Experience 0.0 100.0 Yes 8.3
20 Kgabo CHC Odi Yes Adequate 8.8 69.5 27.4 66.7 Experience 0.0 76.2 Yes 83.3
21 Mpho Ya Batho Clinic Odi Yes Adequate 4.6 57.7 65.8 18.2 Experience 0.0 100.0 Yes 20.0
22 Phedisong 1 CHC Odi Yes Adequate 6.7 88.9 41.0 25.0 Experience 0.0 70.0 Yes 85.7
23 Atteridgeville Clinic CTMM No Inadequate 9.6 77.6 85.7 14.3 Experience 0.0 90.5 NO -
24 Danville Clinic CTMM No Inadequate 5.6 - 53.5 50.0 Max-Min 91.7 87.5 NO 12.5
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T a b le  A 3  In d ic a to r s  fo r  D r u g  P r o c u r e m e n t ,  A v a i la b i l i ty  a n d  C o n tr o l
No F a c i l i ty T y p e O w n e r
H a s
all
S O P s
R e c e iv in g
p r o c e d u r e s
L ea d
T im e
(d a y s )
%
O r d e r
S u p p l ie d
O r d e r in g
In terv a l
(d a y s )
% o /s
in
y e a r
Q u a n t .
M e th o d
%  has  
R O L
%  in 
S to c k
U se
s to ck
c a r d s
%
C a r d = S h e l f
25 Folang Clinic C T M M No Inadequate 16.2 74.2 86.0 16.0 Max-Min 80.0 96.0. NO -
26 Gazankulu Clinic C T M M No Inadequate - 93.8 - 15.0 Max-Min 80.0 70.0 NO -
27 Hercules Clinic C T M M No Adequate 10.6 73.7 126.4 26.9 ROL 0.0 92.3 NO -
28 Karenpark Clinic C T M M Yes Adequate 18.0 - 95 5 50.0 ROL 0.0 70.8 Yes 81.0
29 Laudium Clinic C T M M Yes Inadequate 12.7 92.9 61.4 - Experience 0.0 100.0 NO -
30 Lyttelton Clinic C T M M Yes Adequate 14.8 78.3 71.5 - Max-Min - - Yes -
31 Mamelodi West Clinic C T M M No Inadequate 23.2 - 84.5 17.6 Max-Min 0.0 93.8 NO -
32 Phahameng Clinic C T M M No Adequate 19.1 75.6 87.9 16.7 Max-Min 75.0 78.3 NO -
33 Phomolong Clinic C T M M No Inadequate 12.7 76.9 52.6 10.5 Max-Min 84.2 94.7 NO -
34 Rosslyn Clinic C T M M Yes Adequate 10.2 93.3 51.4 11.1 ROL 61.1 100.0 Yes 62.5
35 Silverton Clinic C T M M No Adequate 22.5 78.3 56.3 60.9 Max-Min 60.9 91.3 NO -
36 Stanza Bopape 2 Clinic C T M M No Inadequate 10.0 75.0 98.6 35.0 Max-Min 90.0 90.0 NO -
M e a n 11.2 79 .0 56.1 33.1 3 3 .8 8 7 .6 55 .9
M a x im u m 23.2 9 7 .7 126 .4 83 .3 10 0 .0 100 .0 1 0 0 .0
M in im u m 3.4 5 7 .7 16.5 0 .0 0 .0 7 0 .0 8.3
P E R F O R M A N C E  T A R G E T Y e s A d e q u a t e - 95 - < 1 0
R O L /M i n -
M a x
100 9 0 Y e s 100
%  o f  c l in ic s  w h ic h  m e e t  ta r g e t 47 5 6 - 4 - 7 53 3 58 67 4
SOPs = Standard operating procedures, O/S = Out o f stock, ROL = Re-Order Level, % has ROL = Percentage o f tracer items whose Re-Order 
Level had been determined, Min-Max = Minimum-Maximum level, Card=Shelf means the balance quantity on the card was equal to the quantity
physically on the shelf.
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Table A4 Supplying Primary Health Care Facilities from Sub-depots Compared
to Hospital Pharmacies
F a c i l i ty T y p c O w n e r L e a d  T i m e / d a y s %  O r d e r O u t  o f  S t o c k /d a y s % in  S to c k
A v e r a g e R a n g e S u p p l ie d M a x % la s t  y e a r
Atteridgeville Clinic CTMM 9.6 6 to 13 77.6 40 14.3 90.5
Danville Clinic CTMM 5.6 5 to 7 127 50.0 87.5
Folang Clinic CTMM 16.2 5 to 46 74.2 33 16.0 96.0
Gazankulu Clinic CTMM - - 93.8 149 15.0 70.0
Hercules Clinic CTMM 10.6 1 to 12 73.7 337 26.9 92.3
Karenpark Clinic CTMM 18.0 6 to 55 - 8 50.0 70.8
Laudium Clinic CTMM 12.7 1 to 26 92.9 - - 100.0
Lyttelton Clinic CTMM 14.8 1 to34 78.3 - - -
Mamelodi West Clinic CTMM 23.2 12 to 77 - 132 17.6 93.8
Phahameng Clinic CTMM 19.1 1 to 53 75.6 69 16.7 78.3
Phomolong Clinic CTMM 12.7 9 to 25 76.9 26 10.5 94.7
Rosslyn Clinic CTMM 10.2 7 to 20 93.3 14 11.1 100.0
Silverton Clinic CTMM 22.5 7 to 41 78.3 51 60.9 91.3
Stanza Bopape 2 Clinic CTMM 10.0 4 to 34 75.0 295 35.0 90.0
Boikhutsong Clinic GPA - - - - - 82.4
Bophelong Clinic GPA 3.4 1 tO 5 90.0 21 20.0 81.0
Eestenist Clinic GPA 14.1 13 to 27 82.1 54 39.1 95.7
Laudium CHC GPA 7.0 5 to 18 78.8 70 12.5 90.6
Mandisa Shiceka Clinic GPA 9.1 9 to 10 77.2 14 11.1 92.6
Pretoria North Clinic GPA 3.7 1 to 14 86.5 0 0.0 89.5
Skinner Street Clinic GPA - - - - - -
Soshanguve3 CHC GPA 10.6 1 to 39 28 26.3 94.7
Soshanguve JJ Clinic GPA - - - - - -
Stanza Bopape CHC GPA 9.5 2 to 13 83.8 0 0.0 93.8
Sedibeng HC Clinic GPA 3.6 1 to 9 97.7 45 59.1 78.3
Jubilee Gateway Clinic Moretele 17.1 17 to 18 - 39 83.3 83.3
New Eersterust Clinic Moretele 9.3 8 to 11 - 56 40.9 90.9
Ramotse Clinic Moretele 15.8 3 to 18 - 95 33.3 70.8
Refentse CHC Moretele 9.8 8 to 17 86.7 72 46.2 88.0
Suurman Clinic Moretele 9.3 4 to 15 74.7 58 70.0 75.0
Temba CHC Moretele 11.4 8 to 24 70.1 71 73.9 91.3
Boekenhout CHC OD1 7.5 4 to 13 61.9 81 42.9 90.0
Itireleng Clinic ODI 12.6 7 to 19 57.9 100.0
Kgabo CHC ODI 8.8 7 to 9 69.5 89 66.7 76.2
Mpho ya Batho Clinic ODI 4.6 2 to 8 57.7 129 18.2 100.0
Phedison I CHC ODI 6.7 6 to 9 88.9 18 25.0 70.0
1 1
Overall Average
’O  A ■ t i l M K ' 1
11.2
v
79.0 s 33.1 87.6Average(*CTMM+GPA) 11.7 82.5 24.6 88.8Average(**Moretele+Odi) 10.3 70.9 50.0 85.0
*Sub-depots. **Hospit;il pharmacies. CTMM = City of Tshwane Metropolitan Municipality. GPA 
= Gauteng Provincial Authority, CHC = Community Health Centre
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Table A5 Relationship between Staff in-charge of Drug Supply Management,
Nature of Deployment and some Drug Supply Management Indicators
F a c il ity T y p e O w n e r In c h a r g e  o f  D S M R e s tr ic t
a c c e ss
A d e q u a te
R e c e iv in g
p r o c e d u r e s
S to ck  
o f f  th e  
f lo o rQ u a lif ic a t io n D u ra tio n
Suurman Clinic Moretele Nurse (Enrld) Permanent X V V
Kgabo CHC ODI Nurse (Enrld) Permanent V V V
Stanza Bopape CHC GPA Nurse (Enrld) Rotation X X V
Ramotse Clinic Moretele Nurse (Enrld) Rotation X X X
Temba CHC Moretele Nurse (Enrld) Rotation V V V
Gazankulu Clinic CTMM Nurse (Reg) Permanent V X X
Hercules Clinic CTMM Nurse (Reg) Permanent X V X
Karenpark Clinic CTMM Nurse (Reg) Permanent X V V
Laudium Clinic CTMM Nurse (Reg) Permanent V X X
Lyttelton Clinic CTMM Nurse (Reg) Permanent X V V
Rosslyn Clinic CTMM Nurse (Reg) Permanent V V V
Boikhutsong Clinic GPA Nurse (Reg) Permanent V V V
Bophelong Clinic GPA Nurse (Reg) Permanent V X X
Eestemst Clinic GPA Nurse (Reg) Permanent V V X
Pretoria North Clinic GPA Nurse (Reg) Permanent V V X
Skinner Street Clinic GPA Nurse (Reg) Permanent V V X
Soshanguve JJ Clinic GPA Nurse (Reg) Permanent X X V
Sedibeng HC Clinic GPA Nurse (Reg) Permanent X V V
Refen tse CHC Moretele Nurse (Reg) Permanent V V X
Itireleng Clinic ODI Nurse (Reg) Permanent X X V
Silverton Clinic CTMM Nurse (Reg) Rotation V V X
Laudium CHC GPA Nurse (Reg) Rotation X V X
Mandisa Shiceka Clinic GPA Nurse (Reg) Rotation V V V
Soshanguve3 CHC GPA Nurse (Reg) Rotation V X V
Jubilee Gateway Clinic Moretele Nurse (Reg) Rotation X X V
New Eersterust Clinic Moretele Nurse (Reg) Rotation X X V
Boekenhout CHC ODI Nurse (Reg) Rotation X V V
Mpho ya Batho Clinic ODI Nurse (Reg) Rotation X V X
Phedisong 1 CHC ODI Nurse (Reg) Rotation X V V
Mamelodi West Clinic CTMM Pharm Asst Permanent X X V
Atteridgeville Clinic CTMM Pharm Asst Rotation X X X
Danville Clinic CTMM Pharm Asst Rotation X X X
Folang Clinic CTMM Pharm Asst Rotation V X V
Phahameng Clinic CTMM Pharm Asst Rotation X V V
Phomolong Clinic CTMM Pharm Asst Rotation V X V
Stanza Bopape 2 Clinic CTMM Pharm Asst Rotation X X V
O d d  R a tio  : P A  v e r su s  N u r se  (R e g + E n r ld ) O R 0.429 0.088 1.765
O d d  R a tio  : P e r m a n e n t  v e r su s  R o ta tio n O R 2.500 2.500 0.625
V = Yes, X = No, Reg = Registered, CTMM = City of Tshwane Metropolitan Municipality, GPA =
Gauteng Provincial Authority, CHC = Community Health Centre
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Table A6 Effect of the Number of Staff Trained in Drug Supply Management on
some Drug Supply Management Indicators
F a c i l i ty T y p e O w n e r N o
T r a in e d  
in  D S M
%  I te m s  
S t o c k = c a r d
R e s tr ic t
a c c e s s
A d e q u a t e
R e c e iv in g
p r o c e d u r e s
S to c k  
o f f  the  
f lo o r
Kgabo CHC ODI 16 83.3 V V V
Temba CHC Moretele 11 87.0 V V V
Skinner Street Clinic GPA 10 - V V X
Eestemst Clinic GPA 8 46.2 V V X
Boekenhout CHC ODI 6 16.7 X V V
Mandisa Shiceka Clinic GPA 5 55.6 V V V
Boikliutsong Clinic GPA 4 61.1 V V V
Landium CHC GPA 4 28.1 X V X
Phedisong I CHC ODI 4 85.7 X V V
Soshanguve3 CHC GPA 4 31.6 V X V
Hercules Clinic CTMM 3 - X V X
Stanza Bopape CHC GPA 3 62.5 X X V
Mpho ya Batho Clinic ODI 2 20.0 X V X
Stanza Bopape 2 Clinic CTMM 2 - X X V
Suurman Clinic Moretele 2 90.9 X V V
Atteridgeville Clinic CTMM 1 - X X X
Bophelong Clinic GPA 1 54.5 V X X
Danville Clinic CTMM 1 12.5 X X X
Folang Clinic CTMM 1 - V X <
Jubilee Gateway Clinic Moretele 1 54.5 X X V
Karenpark Clinic CTMM 1 81.0 X V V
Lyttelton Clinic CTMM 1 - X V V
Ph ah am eng Clinic CTMM 1 - X < V
Phomolong Clinic CTMM 1 - V X V
Pretoria North Clinic GPA 1 26.3 V V X
Ramotse Clinic Moretele 1 85.7 X X X
Refentse CHC Moretele 1 64.0 V V X
Rosslyn Clinic CTMM 1 62.5 V V V
Sedibeng HC Clinic GPA 1 100.0 X V V
Soshanguve JJ Clinic GPA 1 - X X V
Itireleng Clinic ODI 0 8.3 X X V
Laudium Clinic CTMM 0 - V X X
New Eersterust Clinic Moretele 0 66.7 X X V
Silverton Clinic CTMM 0 - V V X
Gazankulu Clinic CTMM - - V X X
Mamelodi West Clinic CTMM - - X X V
Odd Ratio: 1 Vs 0 trained in DSM OR 0 .765 5.182 1.727
Correlation with No. trained in DSM r + 0 .194
V = YES, X = NO, CTMM = City of Tshwane Metropolitan Municipality, GPA = Gauteng Provincial
Authority, CHC = Community Health Centre, DSM = Drug Supply Management
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Table A7 Impact of Determining Re-Order Level/Minimum-Maximum Levels on
Drug Availability Indicators
Facility Type Owner % Items with
ROL/Max
% Out of 
Stock last 
year
% in Stock % Prescribed 
drugs 
dispensed
Laudium CHC GPA 100.0 12.5 90.6
Danville Clinic CTMM 91.7 50.0 87.5 100.0
Stanza Bopape 2 Clinic CTMM 90.0 35.0 90.0 100.0
Mandisa Shiceka Clinic GPA 88.9 11.1 92.6 100.0
Stanza Bopape CHC GPA 87.5 0.0 93.8 -
Phomolong Clinic CTMM 84.2 10.5 94.7 96.5
Folang Clinic CTMM 80.0 16.0 96.0 -
Gazankulu Clinic CTMM 80.0 15.0 70.0 -
Phahameng Clinic CTMM 75.0 16.7 78.3 100.0
Soshanguve 3 CHC GPA 63.2 26.3 94.7 -
Rosslyn Clinic CTMM 61.1 11.1 100.0 -
Silverton Clinic CTMM 60.9 60.9 91.3 100.0
Suurman Clinic Moretele 60.0 70.0 75.0 -
Bophelong Clinic GPA 50.0 20.0 81.0 100.0
Temba CHC Moretele 43.5 73.9 91.3 -
Atteridgeville Clinic CTMM 0.0 14.3 90.5 -
Boekenhout CHC ODI 0.0 42.9 90.0 -
Boikhutsong Clinic GPA 0.0 - 82.4 -
Eesterust Clinic GPA 0.0 39.1 95.7 100.0
Hercules Clinic CTMM 0.0 26.9 92.3 100.0
Itireleng Clinic ODI 0.0 - 100.0 -
Jubilee Gateway Clinic Moretele 0.0 83.3 83.3 -
Karenpark Clinic CTMM 0.0 50.0 70.8 -
Kgabo CHC ODI 0.0 66.7 76.2 -
Laudium Clinic CTMM 0.0 - 100.0 -
Mamelodi West Clinic CTMM 0.0 17.6 93.8 100.0
Mpho ya Batho Clinic ODI 0.0 18.2 100.0 -
New Eersterust Clinic Moretele 0.0 40.9 90.9 -
Phedison I CHC ODI 0.0 25.0 70.0 -
Pretoria North Clinic GPA 0.0 0.0 89.5 100.0
Ramotse Clinic Moretele 0.0 33.3 70.8 93.6
Refentse CHC Moretele 0.0 46.2 88.0 -
Sedibeng HC Clinic GPA 0.0 59.1 78.3 98.1
Lyttelton Clinic CTMM - - - -
Skinner Street Clinic GPA - - - -
Soshanguve JJ Clinic GPA - - - -
Correl. with % of Items with ROL r -0.299 0.104 0.200
ROL/Max = Re-Order Level and Minimum-Maximum Level, CTMM = City of Tshwane Metropolitan 
Municipality, GPA = Gauteng Provincial Authority, CHC = Community Health Centre,
Correl = Correlation
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Tab e A8 Summary of Qualitative Observations*
F a c i l i t y T y p e O w n e r In c h a r g e  o f  D S M N u m b e r  T r a in e d
A c c e s s
P o l icy
S t o r a g e  F a c i l i t ie s
Q u a l i f i c a t io n D u r a t io n D S M R D U C C M R e str ic te d S ize B u r g .p r o o f O f f  th e  f lo o r V e n t i la t io n R o o m  T e m p R e c .C a g e
Boikhutsong Clinic GPA Reg.Nurse Permanent 4 10 10 Yes Adequate Yes Yes AC Yes No
Bophelong Clinic GPA Reg.Nurse Permanent 1 0 1 Yes Inadequate Yes No AC No No
Eesterust Clinic GPA Reg.Nurse Permanent 8 7 - Yes Inadequate No No Ceiling No No
Laudium CHC GPA Reg.Nurse Rotation 4 16 16 No Inadequate Yes No AC No Yes
Mandisa Shiceka Clinic GPA Reg.Nurse Rotation 5 0 5 Yes Adequate Yes Yes AC No No
Pretoria North Clinic GPA Reg.Nurse Permanent 1 17 4 Yes Inadequate No No AC No No
Skinner Street Clinic GPA Reg.Nurse Permanent 10 0 10 Yes Inadequate Yes No AC No No
Soshanguve 3 CHC GPA Reg.Nurse Rotation 4 - 3 Yes Inadequate Yes Yes AC No No
Soshanguve JJ Clinic GPA Reg.Nurse Permanent 1 1 7 No Inadequate No Yes Ceiling No No
Stanza Bopape CHC GPA Enrld Nurse Rotation 3 11 3 No Inadequate Yes Yes AC No No
Sedibeng HC Clinic GPA Reg.Nurse Permanent 1 2 0 No Inadequate Yes Yes Desk fan No No
Jubilee Gateway Clinic Moretele Reg.Nurse Rotation 1 1 0 No Inadequate No Yes Ceiling No No
New Eersterust Clinic Moretele Reg.Nurse Rotation 0 1 1 No Inadequate No Yes Ceiling No No
Ramotse Clinic Moretele Enrld Nurse Rotation 1 1 1 No Inadequate Yes No Ceiling No No
Refentse CHC Moretele Reg.Nurse Permanent 1 0 0 Yes Inadequate No No Ceiling No No
Suurman Clinic Moretele Enrld Nurse Permanent 2 2 2 No Inadequate Yes Yes Desk fan No No
Temba CHC Moretele Enrld Nurse Rotation 11 11 11 Yes Adequate Yes Yes Ceiling No No
Boekenhout CHC ODI Reg.Nurse Rotation 6 6 6 No Inadequate No Yes Ceiling No No
Itireleng Clinic ODI Reg.Nurse Permanent 0 0 0 NO Inadequate No Yes Ceiling No No
* DSM = Drug Supply Management, RDU = Rational Drug Use, CCM = Cold Chain Management, CTMM = City of Tshwane Metropolitan Municipality, GPA = Gauteng 
Provincial Authority, CHC = Community Health Centre, Burg. = Burglar, Rec.= Receiving, AC = Air Conditioner.
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Tab e A8 Summary of Qualitative Observations*
F a c i l i t y T y p e O w n e r In c h a r g e  o f  D S M N u m b e r  T r a in e d
A c c e s s
P o licy
S t o r a g e  F a c i l i t ie s
Q u a l i f ic a t io n D u r a t io n D S M R D U C C M R e s tr ic te d S ize B u r g .p r o o f O f f  th e  f loor V e n t i la t io n R o o m  T e m p R e c .C a g e
Kgabo CHC ODI Enrld Nurse Permanent 16 16 27 Yes Adequate No Yes Ceiling No No
Mpho ya Batho Clinic ODI Reg.Nurse Rotation 2 0 0 No Inadequate No No Ceiling No No
Phedison I CHC ODI Reg.Nurse Rotation 4 1 0 No Adequate No Yes Ceiling No No
Atteridgeville Clinic CTMM Pharm Asst Rotation 1 5 6 No Adequate Yes No AC No No
Danville Clinic CTMM Pharm Asst Rotation 1 3 1 No Inadequate Yes No AC No No
Folang Clinic CTMM Pharm Asst Rotation 1 10 1 Yes Adequate Yes Yes AC No No
Gazankulu Clinic CTMM Reg.Nurse Permanent 1 1 Yes Inadequate No No Desk fan No No
Hercules Clinic CTMM Reg.Nurse Permanent 3 3 3 No Inadequate Yes No AC No Yes
Karenpark Clinic CTMM Reg.Nurse Permanent 1 4 0 No Adequate Yes Yes AC Yes No
Laudium Clinic CTMM Reg.Nurse Permanent 0 5 5 Yes Adequate Yes No AC No No
Lyttelton Clinic CTMM Reg.Nurse Permanent 1 6 1 No Adequate Yes Yes AC Yes No
Mamelodi West Clinic CTMM Pharm Asst Permanent - - No Adequate Yes Yes AC No No
Phahameng Clinic CTMM Pharm Asst Rotation 1 5 5 No Inadequate Yes Yes AC No No
Phomolong Clinic CTMM Pharm Asst Rotation 1 6 2 Yes Adequate Yes Yes AC No Yes
Rosslyn Clinic CTMM Reg.Nurse Permanent 1 5 1 Yes Adequate Yes Yes AC No No
Silverton Clinic CTMM Reg.Nurse Rotation 0 3 1 Yes Adequate No No AC Yes No
Stanza Bopape 2 Clinic CTMM Pharm Asst Rotation 2 10 8 No Adequate Yes Yes AC No No
T A R G E T P h a r m  A ss t
P e r m a n e
nt 1 1 1 Y e s A d e q u a t e Y e s Y e s A C /F a n Y e s Y e s
% w h o  c o m p ly 19 % 5 0 % 8 8 % 8 2 % 7 9 % 4 4 % 4 2 % 6 4 % 6 1 % 6 7 % 11 % 8 %
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Table A8 Summary o ‘Qualitative Observations*
Facility Type Owner Separate storage for Has Phone Has Fax Type of Fridge Cold Chain Management
Flammables Schedule 5 EPI Domestic Has fridge Stock in door Food in Fridge Daily Therm Type Back-up
Boikhutsong Clinic GPA N/A Yes Yes Yes - - No - - - - -
Bophelong Clinic GPA N/A Yes Yes Yes - Yes Yes No No Yes Actual Yes
Eesterust Clinic GPA Yes Yes Yes Yes - Yes Yes Yes No No None No
Laudium CHC GPA Yes Yes Yes Yes Yes - Yes No No Yes Min-Max Yes
Mandisa Shiceka Clinic GPA No No Yes Yes Yes - Yes No No Yes Actual No
Pretoria North Clinic GPA No Yes Yes Yes Yes - Yes No No Yes Actual No
Skinner Street Clinic GPA Yes Yes Yes Yes - Yes Yes No Yes Yes Actual No
Soshanguve 3 CHC GPA No Yes Yes Yes Yes - Yes No No Yes Actual Yes
Soshanguve JJ Clinic GPA N/A No Yes No - Yes Yes No Yes No None No
Stanza Bopape CHC GPA N/A Yes Yes Yes - Yes Yes No No Yes Min-Max Yes
Sedibeng HC Clinic GPA No N/A Yes Yes - No - - - - -
Jubilee Gateway Clinic Moretele N/A No Yes No - Yes Yes Yes No Yes Actual Yes
New Eersterust Clinic Moretele N/A N/A No No - Yes Yes Yes No Yes Actual No
Ramotse Clinic Moretele N/A N/A Yes No - Yes Yes No No No Actual No
Refentse CHC Moretele N/A Yes Yes No Yes - Yes No No Yes Actual No
Suurman Clinic Moretele N/A Yes No No - - No - - - - -
Temba CHC Moretele N/A Yes Yes No - Yes Yes Yes No Yes Actual No
Boekenhout CHC ODI No N/A Yes No Yes - Yes No No No Actual No
Itireleng Clinic ODI N/A N/A Yes Yes Yes Yes No No No Actual No
Kgabo CHC ODI N/A Yes Yes Yes Yes - Yes No No Yes Actual No
* CTMM = City of Tshwane Metropolitan Municipality, GPA = Gauteng Provincial Authority, CHC = Community Health Centre, EPI = Expanded Programme of 
Immunisation, Min-Max = Minimum- Maximum, Therm. = Thermometer.
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Table A8 Summary o 'Qualitative Observations*
Facility Type Owner Separate storage for Has Phone Has Fax Type of Fridge Cold Chain Management
Flammables Schedule 5 EPI Domestic Has fridge Stock in door Food in Fridge Daily Therm Type Back-up
Mpho ya Batho Clinic ODI N/A N/A Yes No Yes - Yes No No Yes Actual No
Phedison I CHC ODI N/A Yes Yes No Yes - Yes No No Yes Actual No
Atteridgeville Clinic CTMM N/A N/A Yes Yes - Yes Yes No No Yes Min-Max No
Danville Clinic CTMM N/A Yes Yes No - Yes Yes No No Yes Min-Max No
Folang Clinic CTMM N/A N/A Yes No - Yes Yes Yes No Yes Min-Max Yes
Gazankulu Clinic CTMM N/A N/A Yes No - Yes Yes No No Yes Min-Max No
Hercules Clinic CTMM No Yes Yes No - Yes Yes No Yes Yes Min-Max No
Karenpark Clinic CTMM No N/A Yes Yes Yes - Yes No No Yes Min-Max No
Laudium Clinic CTMM N/A N/A Yes Yes Yes Yes No No Yes Min-Max No
Lyttelton Clinic CTMM No Yes Yes Yes Yes Yes Yes No No Yes Min-Max No
Mamelodi West Clinic CTMM N/A Yes Yes No - Yes Yes Yes No Yes Min-Max No
Phahameng Clinic CTMM No Yes Yes No - Yes Yes No No Yes Min-Max No
Phomolong Clinic CTMM N/A Yes Yes No - Yes Yes No No Yes Min-Max No
Rosslyn Clinic CTMM N/A N/A Yes Yes Yes - Yes No No Yes Actual No
Silverton Clinic CTMM No Yes Yes No - Yes Yes No No Yes Min-Max No
Stanza Bopape 2 Clinic CTMM No Yes Yes No - Yes Yes No No Yes Min-Max No
TARGET Yes Yes Yes Yes Yes Yes N o N o Yes Min-Max Yes
% who comply 8% 58% 94% 47% 36% 92% 82% 91% 85% 45% 18%
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Table A8 Summary of Qualitative Observations4
F a c i l i ty T y p e O w n e r P R O C E D U R E S M E D I C I N E  B U D G E T
A ll S O P s Q u a n t i f i c a t io n R e c e iv in g S to c k  c a r d s K n o w s % L a s t  y e a r %  T h is  y e a r C o n tr o l
Boikhutsong Clinic GPA Yes Max-Min Adequate Yes Yes 74 31.1 Yes
Bophelong Clinic GPA Yes ROL Inadequate Yes Yes No figure 45.6 No
Eesterust Clinic GPA No Experience Adequate NO No 145.2 Not calc No
Laudium CHC GPA Yes ROL Adequate Yes Yes Only exp Only exp Yes
Mandisa Shiceka Clinic GPA No ROL Adequate Yes Yes Don't know Not calc No
Pretoria North Clinic GPA No Experience Adequate Yes No Don't know Don’t know No
Skinner Street Clinic GPA No ROL Adequate Yes Yes Disputed 30.3 Yes
Soshanguve 3 CHC GPA Yes ROL Inadequate Yes Yes 139.1 96.8 No
Soshanguve JJ Clinic GPA No Experience Inadequate Yes No None None No
Stanza Bopape CHC GPA Yes ROL Inadequate Yes Yes 94.1 Not calc No
Sedibeng HC Clinic GPA No Experience Adequate Yes No 116.5 Only exp No
Jubilee Gateway Clinic Moretele Yes Experience Inadequate Yes No None None No
New Eersterust Clinic Moretele No Experience Inadequate Yes No Only exp Only exp No
Ramotse Clinic Moretele No Experience Inadequate Yes No Don't know Not calc No
Refentse CHC Moretele Yes Experience Adequate Yes No Don't know Not calc No
Suurman Clinic Moretele Yes Experience Adequate Yes No Don't know Not calc No
Temba CHC Moretele Yes Experience Adequate Yes Yes R 221,369 R 117,670 No
Boekenhout CHC ODI Yes Experience Adequate Yes No Don't know Not calc No
Itireleng Clinic ODI No Experience Inadequate Yes No Don't know Not calc No
Kgabo CHC ODI Yes Experience Adequate Yes No Don't know Not calc No
* CTMM = City of Tshwane Metropolitan Municipality, GPA = Gauteng Provincial Authority, CHC = Community Health Centre, SOPs = Standard Operating Procedures, 
ROL = Re-Order Level, calc. = calculated, Min-Max = Minimum-Maximum Level.
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Table A8 Summary of Qualitative Observations4
F a c ility T y p e O w n e r P R O C E D U R E S M E D IC IN E  B U D G E T
A ll S O P s Q u a n t if ic a t io n R e c e iv in g S to c k  c a r d s K n o w s % L a st  y e a r % T h is  y e a r C o n tr o l
Mpho ya Batho Clinic ODI Yes Experience Adequate Yes No Don’t know Not calc No
Phedison I CHC ODI Yes Experience Adequate Yes No Don’t know Not calc No
Atteridgeville Clinic CTMM No Experience Inadequate NO No Don’t know Not calc No
Danville Clinic CTMM No Max-Min Inadequate NO No Don't know Not calc No
Folang Clinic CTMM No Max-Min Inadequate NO No Don't know Not calc No
Gazankulu Clinic CTMM No Max-Min Inadequate NO Yes Don't know Not calc No
Hercules Clinic CTMM No ROL Adequate NO No Don't know Not calc No
Karenpark Clinic CTMM Yes ROL Adequate Yes Yes Only exp 47.7 No
Laudium Clinic CTMM Yes Experience Inadequate NO Yes Don't know Not calc Yes
Lyttelton Clinic CTMM Yes Max-Min Adequate Yes Yes Don't know Not calc Yes
Mamelodi West Clinic CTMM No Max-Min Inadequate NO No Don't know Not calc No
Phahameng Clinic CTMM No Max-Min Adequate NO Yes Don't know Not calc Yes
Phomolong Clinic CTMM No Max-Min Inadequate NO No Don't know Don’t know No
Rosslyn Clinic CTMM Yes ROL Adequate Yes Yes Don't know Not calc No
Silverton Clinic CTMM No Max-Min Adequate NO No Don't know 32.1 Yes
Stanza Bopape 2 Clinic CTMM No Max-Min Inadequate NO Yes Don't know 45.4 Yes
T A R G E T Y e s R O L /M in -M a x A d e q u a te Y e s Y es Y es
%  w h o  c o m p ly 4 7 % 53% 5 6 % 67 % 42 % 22 %
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APPENDIX B:
TOOLS USED IN DATA COLLECTION
8 0
APPENDIX B1 Description of the WHO and HST Drug Supply Management 
Indicators, their Purpose and Method of Calculation
INDICATOR PURPOSE CALCULATION
Prescribing Indicators
1 Average number o f drugs per encounter.
To measure the degree o f 
polypharmacy.
Divide total number o f drugs 
prescribed by the number of 
encounters surveyed.
2
% o f drugs 
prescribed by 
generic name
To measure the tendency to 
prescribe by generic name to 
allow generic substitution as a 
cost-minimisation strategy.
Divide the number o f drugs 
prescribed by generic name by the 
total number o f drugs prescribed, 
multiplied by 100%.
3
% o f encounters 
with an antibiotic 
prescribed.
To measure the overall level o f 
use o f two important, but 
commonly overused and costly 
forms o f drug therapy.
Divide the number o f patient 
encounters with an antibiotic or 
injection prescribed, by the total 
number o f  encounters surveyed, 
multiplied by 100%.4
% o f encounters 
with an injection 
prescribed.
5
% o f drugs 
prescribed from the 
EDL.
To measure the degree to 
which practices conform to a 
national drug policy as 
indicated by prescribing from 
the national EDL for the type 
o f facility.
Divide the number o f products 
prescribed which are listed on the 
EDL, by the total number o f 
products prescribed, multiplied by 
100%.
Drug Procurement, Availability and Control Indicators
6 Availability o f  key drugs.
To measure the availability at 
health facilities o f  key drugs 
recommended for treatment o f 
some common health 
problems.
Divide the number o f specified 
products actually in stock by total 
number o f drugs on the checklist, 
multiplied by 100%
7
% o f drugs ordered 
that are supplied 
within the delivery 
schedule
To measure the service level 
o f the supplier to the health 
facility.
Divide the total number o f drugs 
issued, by the total number o f drugs 
ordered, multiplied by 100%
8 Adequate receiving procedure.
To identify measures that 
support drug control and 
accountability in the supply 
chain.
Identify where received drugs were 
checked against orders and invoices 
before use, and any discrepancies 
formally reported within a stipulated 
period, as adequate.
9 Lead Time.
To measure how long the 
supplier takes to deliver 
ordered items.
Measure the duration in days it takes 
from date a tracer item is ordered to 
the time it is received.
10 Ordering Interval.
To measure the frequency o f 
ordering whether it is in line 
with the schedule and safety 
levels.
Measure the duration in days 
between two most recent 
consecutive ordering dates for each 
tracer item.
11
% o f Tracer items 
that had been out o f 
stock at least once in
To measure the extent to 
which key drugs are not 
available.
Divide the number o f tracer items 
out o f stock at least once in the past 
year, by the total number o f tracer
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INDICATOR PURPOSE CALCULATION
the past year. items checked, multiplied by 100%.
11 Quantification method used.
To identity whether there is an 
adequate method o f 
quantifying drug requirements.
Record the method used out o f Re- 
Order Level method, Minimum- 
Maximum Level Method or mere 
reliance on working experience.
12
% o f items with 
ROL or Min-max 
levels.
To identify the extent to which 
a formal quantification method 
is used.
Divide the number o f tracer items 
with ROL or Min-max levels, by the 
total number o f tracer items checked, 
multiplied by 100%
13 Use o f stock card.
To identify the method used to 
control and account for drugs 
used.
Record whether a standard stock 
card was in use or not.
14
% o f items where 
physical stock 
balanced with the 
record.
To measure the effectiveness 
o f drug control and 
accountability.
Divide the number o f tracer items 
where stock balanced with the 
record, by the total number o f tracer 
items checked, multiplied by 100%.
Cold Chain Management Indicators
15 Type o f fridge available.
To measure availability o f 
adequate storage facilities for 
vaccines.
Record availability o f a fridge and 
they type o f fridge available
16 Stock found stored in the fridge door To identify existence o f some o f the common poor cold 
chain management practices.
Record the presence or not o f stock 
in the fridge door or food or drinks 
in the fridge.17 Food/drinks found stored in the fridge.
18
Recording fridge 
temperature daily 
and the type o f 
thermometer used.
To measure the extent to 
which the cold chain is 
monitored effectively.
Check the type o f thermometer used 
and the temperature chart and note 
whether the fridge temperature is 
monitored daily, including weekends 
and public holidays, or not.
19 Existent o f  a power back-up system.
To measure the ability to 
maintain the cold chain in case 
there is a power failure.
Record existence or not o f an 
alternative source o f power or o f a 
system to protect vaccines from 
damage in cases o f power failure.
Facility Indicators
20 Availability o f an offloading cage.
To identify the availability o f 
facilities to facilitate adequate 
receiving o f drugs and ensure 
they are not used before they 
are checked
Record whether there was a secure 
place where received drugs are 
physically separate and inaccessible 
for use, until they are checked, or 
not.
21
Availability o f a 
store o f adequate 
size.
To identify existent o f a store 
to support good storage 
practices
Record whether the store had the 
size and shelves to hold the 
maximum available stock without 
congestion and placing stock on the 
floor, or not.
22
No stock found 
placed directly on 
the floor.
To identify the adequacy of 
the storage facilities and 
practices.
Record whether any stock was found 
on the floor or not.
23 Adequate store To measure the conditions Record whether a fan or Air
8 2
INDICATOR PURPOSE CALCULATION
ventilation. under which storage o f drugs. conditioning system used or not.
24 Monitoring o f room 
temperature.
To identify whether storage 
conditions were regularly 
monitored.
Record whether there was a 
temperature chart, which showed 
that room temperature in the store 
was regularly monitored.
25 Practice o f  restricted access to the store.
To identify the extent o f drug 
control measures in place.
Record whether access to the store 
was restricted to only one or two 
persons working there, or not.
26
Use o f a double lock 
System
To identify the security 
measures in place for drugs.
Record the existence or not o f either 
two padlocks or two doors on the 
same entrance to the drug store, and 
controlled by two different people.
27 Availability o f Burglar proofing
To identify the security 
measures in place for drugs.
Record whether or not all doors and 
windows (even those not opened 
frequently) were protected by 
burglarproof bars or any other 
system.
28
Existent o f a 
separate store for 
flammable items
To identify extent to which 
special requirements for these 
categories o f items are 
complied with.
Record whether or not a separate 
secure storage area for each o f these 
categories o f items was available and 
being used properly.29
Existent o f a 
separate store for 
schedule >5 items
Personnel Indicators
30
Category o f staff in 
charge o f Drug 
Supply 
Management.
To identify the professional 
appropriateness o f the person 
in charge o f Drug Supply 
Management.
Record the professional training of 
the person usually or found in charge 
o f Drug Supply Management.
31
The nature o f 
deployment o f staff 
for Drug Supply 
Management
To measure whether there is 
continuous accountability for 
drugs.
Record whether the person in charge 
o f Drug Supply Management is 
permanent or there is rotation 
between several health workers.
32
Number o f staff 
trained in DSM, 
RDU or CCM
To measure to what extent the 
personnel are trained in their 
specific areas o f their work.
Record the number o f health workers 
who have received specific training 
in DSM, RDU and CCM.
DSM = Drug Supply Management, RDU = Rational Drug Use, CCM = Cold Chain
Management
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APPEN DIX B2: PRESCRIBING INDICATORS FORM
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APPENDIX B3: DRUG SUPPLY MANAGEMENT LOGISTICS PERFORMANCE INDICATORS FORM
Drug A verage lead tim e O rder interval D uration O/S M ax stock Q uantity o f  stock Expiry FIFO /FE FO
O rd er date Receipt date Lead time 2ndlast order O rder interval Start End O /S RO L O n card O n sh e lf 1 not expired Any expired
A m o x y  c a p s  2 5 0 m g  1 5s
A m o x v  c a p s  2 5 0 m g  3 0 s
A m o x v  c a p s  2 5 0 m g  1 0 0 s
A m o x y  su sp  1 2 5 m g /5 m l 100m l
C ip ro flo x ac in  tab s  5 0 0 m g  10s
P e n e len te  inj 2 .4  m U
P a ra c e t S y r  120m g  5 m l 50m l
P a ra c e t S v r  120n ig  5 m l 100m l
Ib u p ro fe n  tab s  2 0 0 m g  15s
Ib u p ro fe n  tab s  2 0 0 m g  2 8 s
Ib u p ro fe n  tab s  2 0 0 m g  4 2 s
Ib u p ro fe n  tab s  2 0 0 m "  56s
Ib u p ro fe n  ta b s  2 0 0 m g  1 0 0 0 s
H C T Z  ta b s  25 m g  14s
H C T Z  ta b s  25 m g  2 8 s
H C T Z  ta b s  25 m g  5 0 0 s
G lib e n c la in id e  tab s  5 m g  2 8 s
G lib e n c lam id e  ta b s  5 m g  56s
G lib e n c la in id e  tab s  5 m g  500s
M etro n id azo le  tab s  2 0 0 m g  28s
M etro n id azo le  tab s  2 0 0 m g  21s
M etro n id azo le  tab s  2 0 0 m g  250s
P a ra c e tam o l tabs 5 0 0 m g  10s
P a ra c e tam o l tabs 5 0 0 m g  20s
P a ra c e ta m o l tabs 5 0 0 m g  500s
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A d ren a lin e  inj
O R S  Sachets
S a lb u tam o l in h a le r
T e ta n u s  V acc ine
R in g e rs  L a c ta te  IV
Ite m
IV  A dm in . Set 10 D rops
IV  A dm in . Set 15 D rops
IY  A dm in . Set 2 0  D rops
IV  A dm in. Set 6 0  D rops
G lu c o se /K e to n e s  T es t S trip
In s u lin  sy rin g e  1m l
In su lin  sy rin g e  0 .5 m l
S y rin g e  2m l
G lo v e s  n o n -s te rile  sm all-lO O s
G lo v e s  n o n -s te rile  m edium -lO O s
G lo v e s  no n -s te rile  large-lO O s
N o . o f  item s rece iv ed  on la s t o rd e r %
T o ta l N o .o f  item s  o rdered  on  la s t o rder
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APPENDIX B4: HEALTH FACILITY QUESTIONNAIRE
DRUG MANAGEMENT SITUATION ANALYSIS 
FACILITY EVALUATION FORM
Facility Name: 
Location:
Type o f Facility (tick appropriate box):
Clinic
Other
Community Health Centre Hospital Mobile
Date:
Investigators:
A: Personnel and organisational structure
QUESTION RESULTS
Position o f person interviewed
Postal address
Tel:................................................
Fax:...............................................
e-mail:--------------------------------
No o f filled pharmacist posts:— 
No o f vacant pharmacist posts:-
No o f assistant posts filled:------
Basic level:
Post-basic level:
Trainee basic level: 
Trainee post-basic level: 
No o f vacant assistant posts:—
Contact details
Pharmaceutical staff establishment
Location and Position o f Pharmacist 
in-charge_________________________
What is the Qualification o f person 
responsible for drug supply 
management (ordering stock, control 
over storage and issue)?____________
Qualification:
Dedicate/Perm^nent 
Rotational:
Who are the other staff working in 
the Pharmacy or Dispensary?
Title Role Number
Position o f person in a supervisory 
position (e.g. district pharmacist, 
regional pharmacist, clinic 
supervisor)_______________________
How often does the supervisor visit Weekly Monthly
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the facility?
Less often ---------  Specify....................................
No o f personnel in the facility who 
have completed the following 
courses, in addition to their basic 
training.
Drug Supply Management:------------------------------
Rational Drug Use/Effective Prescribing:..............
Cold Chain Management:..........................................
Does the facility have a written 
policy that restricts access to the key 
o f the pharmacy?
Yes No
How many people have a key for the 
pharmacy? Please indicate rank.
No:
Super o f hosp: Matron on duty: 
Casualty staff: Pharmacist: 
Pharmacist Asst.: Other:
B: Physical status of the facility
QUESTION RESULT
Entry and exit- is access to the 
pharmacy/clinic adequate for 
delivery o f medicine from depot?
Yes No
Is there a secure (caged) delivery 
and dispatch area?_________________ Yes No
Is there burglar proofing on ALL 
windows o f the facility, not only 
ones that open?___________________
Yes No
Are flammables stored in a separate 
and secure area? e.g. Ether_________ Yes No
Are potentially abused substances 
and items o f schedule 5 and higher 
stored in a secure place?
Yes No
Is there a separate store from where 
medicines are issued to the 
pharmacy/dispensing points?________
Yes No
Are ALL medicines stored OFF the 
floor on shelves or pallets?_________ Yes No
Mark the option that best describes 
the ventilation process in the 
medicine store
Air conditioned:
Fans:
Air bricks:
Insulation/ceilings in roof: 
Other:
What type o f fridge is used to store 
vaccines?
EPI:
Commercial:
Domestic gas/electric :
Indicate whether the following are 
present(tick if present, cross if 
absent)
Thermometer in/on fridge:
Temperature recorded daily:
(Record actual fridge temp:------------------
Stock packed in door:
Food in fridge (applies to drinking water): 
Ice packs separate :
Back-up generators working:___________
3C)
88
VVM indicators:
Rate the performance o f the 
equipment used by the facility to 
communicate with the 
hospital/deport (only rate what is 
available)
Excellent Adequate Poor
Telephones:.............. ......................... -.........................
Fax :.............................. -........ — --------------
Radio :-------------------- —.......................... ........
E-mail :..................................................................
Comment:— .......................................... -...................
C:
QUESTION RESULTS
Total No o f drugs available in the 
pharmacy. Include all dosage forms 
and pack sizes
No o f drugs listed by generic name 
on the stock sheet/list.
No o f drugs on the stock sheet/list 
which appear on the EDL
Availability o f the Essential Drug 
List/Standard Treatment Guidelines.
Total No o f prescribers and dispensers:
No o f these staff who have a personal copy o f the 
EDL/STG:
Do prescribers have direct access to 
a Provincial Formulary? Yes No
Do prescribers have direct access to 
a list o f drugs available at this 
facility? Elaborate.
Yes No
Indicate which o f the following drug 
information resources are available 
in the facility:
SA Medicines Formulary:
Primary Health Care Medicines Formulary: 
Computer-based resource (e.g. Micromedex CD- 
ROM)
If prescibers require additional 
information about medicines, where 
can they obtain it?
Drug Information Centre:
"Mother" hospital:
Visiting Doctor:
Regional Pharmacist:
Other (specify):............................................................
C: Procurement
QUESTION RESULTS
Where are the medicine supplies 
obtained from?
Regional Pharmacy: 
Local Authority Deport: 
"Mother " hospital: 
Private supplier:
Who prepares the order for 
medicines?
Name:.....................................................................
Position:.................................................................
Who authorises the orders for 
medicines?
Pharmacy/dispensary in-charge: 
Facility Manager:
Area supervisor:
Regional Pharmacist:
How are the quantities to be ordered Re-order level & state ROF:
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determined? Have ROL &/or Max- 
Min levels been determined for each 
drug?
Maximum/minimum order levels: 
Automated system:
Based on experience:
How are orders for drugs placed 
with the supplier?
Requisition book:
Order forms:
By phone; fax; e-mail; post; personal delivery 
Other, specify:
How often are routine orders placed 
with the supplier? Indicate the No of 
routine orders in the past 3 months
How often are emergency orders 
placed with the supplier? Indicate 
the No o f unscheduled orders in the 
past 3 months
Is there written policy on how non- 
EDL drug is obtained for a patient or 
added to the facility’s list? Specify.
Yes No
Where are patients from your facility 
referred to (Referral Route)?
How are drug supplies transported to 
the facility?
Provincial transport:
Courier company:
Dedicated Transport (used only for delivering 
drug supplies):
If repackaging is performed at the 
facility, how may lines are 
packaged? Are the conditions 
adequate?
Tablets/Capsules: 
Liquids/Syrups: 
Extemal/Ointments: 
Antiseptic Solutions:
El: Distribution and storage
QUESTION RESULTS
Are there written SOPs/Guidelines 
for:
• Cold Chain Management
• Organisation o f the store
• Record-keeping
• Schedule 5,6 & 7 subst. control
• Ordering Supplies
• Receiving Supplies
• Disposal o f expired medicines
• Product Recall
• Pest control
Yes No Date o f publication
Indicate which o f the following 
receiving procedures are followed:
Check No o f boxes and sign driver's note: 
Check stock received against delivery note: 
Discrepancy reports submitted to supplier:
Indicate which o f the following 
inventory control procedures are 
used in the store:
Computerised stock control system: 
Stock cards on shelf:
Stock cards in office:
Ordering cards only: 
Maximum/minimum stock levels:
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Reorder levels:
Quantity at time of stocktaking only: 
None:
What system is used to record 
medicines that are dispensed to 
patients, including injectables?
Prescription book: --------------
Tally for @ medicine: --------------
Tally for total No. dispensed: --------------
Quantity to Dispensary/Cupboard: --------------
Other, specify: --------------
None: ...................
When last was a stock-take done in 
the facility? How often is it done?
Date: % Deviation: 
Frequency:
Are there any overstocked or 
obsolete or redundant items on the 
shelves?
Yes No
Budgeting and Finance Management
QUESTION RESULTS
Who determines the Drug Budget for the 
Facility?
Pharmacy In-charge: 
Facility Manager: 
Local Authority: 
Provincial Authority: 
Don’t know:
What criterion is used to determine the 
drug budget for the facility?
Quantification o f needs: 
Rough estimate: 
Previous year’s budget: 
Don’t know:
What is the facility’s budget for drugs for 
the current financial year:
R
Don’t know:
How much o f the budget has been 
consumed to date?
R
Don’t know:
Is the facility budget considered when 
authorising orders?
What was the expenditure in the last 
financial year and how did it relate to the 
budget for that year?
R ( %) 
Don’t know:
What was the cost o f expired stock last 
financial year?
R
Not Valued:
What is the source o f funding for drugs for 
your facility?
Local Authority: 
Provincial Gov’t: 
User fees:
Don’t know:
What are some o f the problems that are encountered in drug management in this 
facility?
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In your opinion what would you recommend as possible solutions to the problems that 
were mentioned above?
Thank you for your time and patience.
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APPENDIX B5: SUB-DEPOT/PHARMACY QUESTIONNAIRE
DRUG MANAGEMENT SITUATION ANALYSIS 
PHARMACY EVALUATION FORM
Pharmacy Name;
Location:______
Date:
Investigators: ------------------------------------
A: Personnel and organisational structure
QUESTION RESULTS
Position o f person interviewed
Postal address
Contact details Tel:— - 
Fax:—  
e-mail:-
Pharmaceutical staff establishment No o f filled pharmacist posts:------------
No o f vacant pharmacist posts:.............
No o f assistant posts filled:....................
No of vacant assistant posts:.............. —
No o f assistants trained and registered:
Basic level:.................................
Post-basic level:........... ..............
No o f assistants in training:
Trainee basic level:....................
_______Trainee post-basic level:---------
Location and Position o f Pharmacist 
in-charge_________________________
Are there non-pharmaceutical 
Personnel involved in handling 
drugs? If  YES, state qualification 
and number.
Yes 
Qualification/
No
>osition Number
To whom does the Pharmacy 
Manager report? State Position and 
and qualification only.______________
Position:
Qualification:
How often does the supervisor visit 
the Pharmacy?
Weekly Monthly
Less often Specify-
Outline the main duties o f pharmacy 
staff. State duty, cadre & no 
involved.
Duty description
Quantification
Ordering
Receiving
Storage
Repackaging
Pricing_________
Cadre Number
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Issuing ........................ ..........  ..............
Picking ...................................  ..............
Dispatch --------------------------  ----------
Preparing Voucher ...................................  ..............
Discrepancies .............................. — -----------
No o f personnel in the Pharmacy 
who have completed the following 
courses(indicate No next to @ 
course title)
Drug Supply Management:.......................................
Rational Drug Use::...............................................—
Cold Chain Management:--------------------------------
Does the Pharmacy have a policy 
that restricts access to the key o f the 
pharmacy?
Yes No
How many people have a key for the 
pharmacy? Please indicate rank.
No:
Pharmacist:
Pharmacist Asst.: Other:
B: Physical status of the Pharmacy
QUESTION
Entry and exit- is access to the 
pharmacy adequate for the largest 
vehicle used for delivery?___________
RESULT
Yes No
Is there a secure (caged) delivery 
and dispatch area?_________________ Yes No
Is there burglar proofing on ALL 
windows o f the Pharmacy, not only 
ones that open?___________________
Yes No
Are flammables stored in a separate 
and secure area? Yes No
Are potentially abused substances 
and items o f schedule 5 and higher 
stored in a secure place?___________
Yes No
Is there a separate dispatch area from 
where medicines are issued to the 
facilities?
Yes No
Are ALL medicines stored OFF the 
floor? Yes No
Mark the option that best describes 
the ventilation process in the 
medicine store. Is room temperature 
monitored and recorded on daily 
basis?
Air conditioned: Yes
Fans:
Airbricks:
Insulation/ceilings in roof: Temp:
Other:
No
What type o f fridge is used to store 
vaccines?
EPI:
Commercial:
Domestic gas/electric 
Walk-in fridge:______
Indicate whether the following are 
present(tick if present, cross if 
absent)
Thermometer in/on fridge: 
Temperature recorded daily: 
(Record actual fridge temp:- 
Stock packed in door:_____
3C)
94
Food in fridge (applies to drinking water): 
Ice packs separate :
Back-up generators working:
VVM indicators:
Rate the performance o f the 
equipment used by the Pharmacy to 
communicate with the facilities and 
suppliers (only rate what is 
available)
Excellent Adequate Poor
Telephones:...................................................................
Fax :............................................  -.................
Radio :...................................................................
E-mail :...................................................................
Comment:.............................................................................. ..........
C:
QUESTION RESULTS
Total No o f drugs available in the 
pharmacy. Include all dosage forms 
and pack sizes
No o f drugs listed by generic name 
on the stock sheet/list.
How are the No and type o f drugs to 
be stocked determined?
No o f non-EDL drugs which appear 
on the PHC stock sheet/list.
Do facilities have access to a list o f 
drugs available at this Pharmacy? Yes ---------  No ---------
Indicate which o f the following drug 
information resources are available 
in the Pharmacy:
SA Medicines Formulary:
Primary Health Care Medicines Formulary:
Provincial Formulary:
PHC EDL/STG:
Computer-based resource (e.g. Micromedex CD-ROM)
C: Procurement
QUESTION RESULTS
Where are the drug supplies 
obtained from?
National Medical Stores: 
Provincial Pharmacy: 
Wholesaler: 
Manufacturer:
What procurement system is used by 
the Pharmacy?
Competitive tender:
Selective biding from pre-selected suppliers: 
Direct purchase:
Government Central Deport:
How are orders for drugs placed 
with the supplier?
Requisition book:
Order forms:
By phone; fax; e-mail; computer link: 
Other, specify:
How are orders for drugs placed by 
the facilities?
Requisition book:
Order forms:
By phone; fax; e-mail; computer link: 
Other, specify:
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Does the sub-depot have authority to 
determine the type and quantity o f 
medicine issued to a PHC facility? 
Explain.
How are the quantities to be ordered 
determined? Have ROL &/or Max- 
Min levels been determined for each 
drug?
Re-order level & state ROF: 
Maximum/minimum order levels: 
Automated system:
Based on experience:
How often are routine orders placed 
with the supplier? Indicate the No o f 
routine orders in the past 3 months
How often are emergency orders 
placed with the supplier? Indicate 
the No o f unscheduled orders in the 
past 3 months
Is there written policy on how non- 
EDL drugs or any drug not on the 
pharmacy list is obtained for a 
patient or added to the Pharmacy’s 
list? Explain.
Yes No
What facilities are supplied by your 
Pharmacy? Specify number o f each 
type o f Pharmacy.
Hospitals:
Community Health Centres: 
Clinics:
Other Public Pharmacies: 
Private Practitioners:
Private Pharmacies:
Other, specify:
Is thei| ' ‘ |xed schedule o f ordering 
and delivery? What is the average 
lead time?
r ___ i no
Lead tim e:--------------------------------days.
How are drug supplies delivered to 
your pharmacy?
Supplier Transport:
Sub-depot dedicated Transport: 
Institution Pool transport: 
Courier company:
Indicate which o f the following 
receiving procedures are followed:
Check No of boxes and sign driver's note + retain copy: 
Check stock received against delivery note: 
Discrepancy reports submitted to supplier:
Specified limit for reporting discrepancies:
Is there a back order system? 
Desribe.
If repackaging is performed at the 
Pharmacy, how may lines are 
packaged? Rate the facilities as 
excellent, Good, Poor.
Yes/No Excellent Good Poor
Tablets/Capsules: .................................................................. -
Liquids/Syrups: ...................................................................
Extemal/Ointments: ........ ......................... - ---------- -------
Antiseptic Solutions: ...............................................................—
Are there guidelines, SOPs and 
BPRs for repackaging? Rate them.
Describe policy on batch numbering 
and expiry dating o f repackaged 
medicine in relation to bulk.
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Are facilities supplied bulk 
medicines for repackaging? Rate the 
guidelines/SOPs given to facilities.
El: Distribution and storage
Yes/No Excellent Good Poor
Tablets/Capsules: ..............................................................—
Liquids/Syrups: ------ --------------------  ---------  -------
Extemal/Ointments: .....................................................  ..........
Antiseptic Solutions: —..................................................  ..........
QUESTION RESULTS
How are drug supplies transported to 
the facilities?
Provincial/District pool transport: 
Dedicated sub-depot Transport: 
Courier company:
Clinic Transport:
Which o f the following dispatch 
procedures are followed?
Final contents check:
Sealing/locking o f parcels:
Dispatch note signed by Pharmacist: 
Delivery note to be signed by recipient: 
Invoice accompanying consignment:
Are ties require submit 
discrepancy reports wlmin a
Yes No ..................... Days.
specified period o f receipt?
How many have been received in the 
last 3 months? Specify.
Description Number Action taken
Are there written SOPs/Guidelines 
for:
• Cold Chain Management
• Organisation o f the store
• Record-keeping
• Schedule 5,6 & 7 subst. control
• Ordering Supplies
• Receiving Supplies
• Disposal o f expired medicines
• Product Recall
• Pest control
Are these or similar guidelines 
availed to the clinics?
Yes No Date o f publication
Does the pharmacy conduct suport 
supevision to the facilities?Who 
does it and at what is the frequency? 
Is there a checklist? Is there written 
feedback?
Yes No
Support supervision: ------------- --------- --------
Checklist: .................  ........................
Written feedback: ------------- ------- -----------
Cadre: —..........................  Frequency:— .................. -
Is FEFO/FIFO practiced in the 
store?
Yes No
Indicate which o f the following 
inventory control procedures are 
used:
Computerised stock control system: 
Stock cards on shelf:
Stock cards in office:
Ordering cards only: 
Maximum/minimum stock levels:
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Reorder levels: 
Other, specify:
When last was a stock-take done in Date: Frequency:
the Pharmacy? How often is it done? % Deviation:
Are there any overstocked or 
obsolete or redundant items on the Yes No
shelves?
Budgeting and Finance Management
QUETION RESULTS
Who determines the Drug Budget for the 
Pharmacy?
Pharmacist In-charge: 
Regional Director: 
District Manager: 
Don’t know:
What criterion is used to determine the 
drug budget for the Pharmacy?
Quantification o f needs: 
Rough estimate: 
Previous year's budget: 
Don’t know:
What is the Pharmacy’s budget for drugs 
for the current financial year:
R
Don’t know:
How much o f the budget has been 
consumed to date?
R
Don’t know:
What was the expenditure in the last 
financial year and how did it relate to the 
budget for that year?
R ( %) 
Don’t know:
What was the cost o f expired stock last 
financial year?
R
Not Valued:
What is the source o f funding for drugs for 
your Pharmacy?
Provincial Gov’t: 
Local Authority: 
Revenue from sales: 
Don’t know:
How are drugs supplied to facilities paid 
for?
Directly by the facility:
By the Region/District after presentation o f a signed 
invoice/delivery note:
Debiting facility deposit accounts:
Who controls to ensure facilities are 
supplied within budget? Is the control 
based on the budget?
Based on budget? YES NO 
Facility Manager:
Area/Cluster Manager: .....................................
Area Pharmacist: ------------ ---------
Other, specify: .....................................
No control: ------------ ---------
How are facilities informed o f the cost o f 
the drugs supplied?
Invoice at time o f delivery: 
Invoice o f total monthly supplies: 
At the end o f the financial year: 
Never informed:
What are some o f the problems that are encountered in drug management in this 
Pharmacy and supplying the facilities?
98
In your opinion what would you recommend as possible solutions to the problems that 
were mentioned above?
Thank you for your time and patience
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APPENDIX B6
DRUG USE IN D IC A TO R S C O N SO U ID A T IO N  FO R M
U ocation :__________________________________________________________  Date:
D ate F acility
A v.drugs
prescribed
%
generics
%
antibiotics
%
injections
% on 
EDL
C onsult
tim e
Disp
tim e
%
drugs
disp
%
adequate
label
% adequate  
know ledge
Im partial
in form at’n
% drugs 
in stock
M ean
Maximum
Minimum
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APPENDIX C: SCHEDULE AND PROGRAMME FOR FIELD VISITS TO HEALTH FACILITIES
NAME OF FACILITY OWNER ADDRESS DISTRICT CONTACT PERSON &TEL. NO
DATE OF 
VISIT
1 . Pretoria Regional Pharm Gauteng Pr. Aut Conr. Bossman andPretorious, Pretoria Central Marla-Twe 0834528955
2. CTMM Sub-depot Local Authority Cnr. Prinsloo and Vermuelen Street Central Vuka Butelezi, 3088804
3. Adelaide Tambo Clinic Gauteng Pr Aut Fanic Van Rensburg Str PYRAMID Central Ms. Julies, 5459937
4. Atteridgeville Clinic Local Authority Mokobane Street, Atteridgeville Central Sr. Makola, 3085111
5. Danville Clinic Local Authority Lucas van der Berg, Transoranje Rd. PTA WEST Central Sr. Maqubela, 3866052
6 Eastlynne Clinic Local Authority Pieter Krynauw Centre, Cnr. Meeu & Stegman Street. EAST LYNNE Central Sr. A. Fisher, 8001419
7. Eersterust Clinic Gauteng Pr. Aut 214 Willie Swarts Ave, EESTERUST Central Sr. L. Leyds, 8067000
8. Eersterust Clinic Local Authority Willie Swartlaan Central Sr. N. Roberts, 8069571
9. Folang Clinic Local Authority D.F. Malan Rylaan, C.De Wet Build. 175 Central Sr. M. Mofokeng, 3080480
10. Gazankulu Clinic Local Authority Mphalane & Makhaza Street Central Sr. V Ngobene, 3757392
11. Hercules Clinic Local Authority Cnr Ribbens & Taljaar street. HERCULES Central Sr. T. Ndlovu 3792039
12. Mamelodi East Clinic Local Authority 11043 Cnr. Lodwaba & Tlou street. Central Sr. Mononyane, 8011041
13. Mamelodi West Clinic Local Authority Cnr. Schabangu & Ntshabeleng Central Sr. Serna, 8054170
14. Mandisa Shiceka Clinic Gauteng Pr. Aut Portion 60 Mandela Village, HAMMANSKRAAL Central Ms. M. Koma, 7113906
15. Nelmapius Clinic Local Authority 494 Lorie Fontein Str. Nelmapius Central Sr. M. Hausler, 8035994
16. Phahameng Clinic Local Authority 19619 Hinterland Ave, Ext. 17, MAMELODI Central Sr. J. Mokale, 8401012
17. Phomolong Clinic Local Authority Cnr. Ndlovu & Dubazana Str, Extension 7 Central Sr. Sibiya, 3756419
18. Pretoria North Clinic Gauteng Pr. Aut 376 Jack Ibodon Str. PRETORIA NORTH Central Ms. R.Mtimkulu, 5656667
19. Pretoria North Clinic Local Authority City Hall, Brits Rd & Emily Hobhou C entral Sr. T. Ndlovu, 5466151
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20. Pretorius Park Clinic Local Authority Cnr Bulge & Loris Street, Pretorius Park Central Sr. M. Haulser, 9986416
21. Sammy Marks Clinic Local Authority Cnr Prinsloo & Vermeulen Street Central Sr. R De Klerk, 3088770
22. Saulsville Clinic Local Authority 33 Sekhu Street, Saulsville Central Sr. M Matsei, 3755946
23. Silverton Clinic Local Authority City Hall, Pretoria Road, Silverton Central Sr. Fisher, 8048958 j
24. Skinner Str Clinic Gauteng Pr. Aut 357 Skinner Str. PRETORIA Central Ms. A. Roux, 3200346
25. Stanza Bopape 2 Local Authority 255905 Hector Petersen, Extension 8 Central Sr. J. Makole, 8401012
26. Stanza Bopape CHC Gauteng Pr. Aut Stand No 2 Shilovhane Str. X5 Mamelodi East Central Ms. J. Mogoboya, 8120336
27. Bophelong Clinic Gauteng Pr. Aut 66 Masokha Str. SAULSVILLE Southern Ms. M. Senosha, 3755955
28. Laudium CHC Gauteng Pr. Aut Cnr. Bengal &25th Ave, LAUDIUM Southern
Ms. S. Kolapan, 
3744022/23
29. Laudium Clinic Local Authority Cnr. 6th Str. & Tangerian Ave, LAUDIUM Southern Mrs. D.Venter, 3742070
30. Lyttelton Clinic Local Authority Cnr. Cantonments & Clifton Southern Sr. A. Hide, 6717289
31. Sedibeng Clinic Gauteng Pr. Aut No.30 Mokobane Str. ATTERIDGEVILLE Southern Sr. S. Slabbert 3736699
32. Boikhutsong Clinic Gauteng Pr. Aut 1266 Block T SOSHANGUVE Northern Ms. M. Mekgbe, 7900091
33. Bronkhorstspruit Clinic Gauteng Pr. Aut
Cnr. Kruger & Botha Str, Muni Forum 
Building, BRONKHORSTSTSPRUIT Northern
Sr. E. Mashia & Sr. A. 
Strydom, 9326200
34. Karenpark Clinic Local Authority Akasia Medical Centre, Hendrik Ave Northern Sr. De Villiers, 5218149
35. Rayton Clinic Gauteng Pr. Aut Cnr. Montey Rose & Oakley Str, RAYTON Northern Ms. C. Broedt, 7344274
36. Refilwe Clinic Gauteng Pr. Aut 1165 Masina Drive COLLINAN Northern Ms. T. Mbeletsi,7320671
37. Rosslyn Clinic Local Authority 91 Piet Rautenbauch street. ROSSLYN Northern Sr.S.Van der Walt,5218312
38. Soshanguve 1 Clinic Gauteng Pr Aut 30 Block II SOSHANGUVE Northern Ms. Amangeipo, 7972233
39. Soshanguve 2 Clinic Gauteng Pr. Aut 1850 Block G SOSHANGUVE Northern Ms. N. Sibulela, 7972714
40. Soshanguve Block JJ Gauteng Pr. Aut 1834 Block BB, SOSHANGUVE Northern Mrs. K.E. Sithole, 7903304
41. Soshanguve CHC (3) Gauteng Pr. Aut 1834 Block BB SOSHANGUVE Northern Ms. L. Sithole, 7903304
42. Dilopye Clinic NWP- Moretele Stinkwater cluster, next to Primary school Stinkwater c/oSr.Mnguni, 0721897355
43. Jubilee Gateway Clinic NWP- Moretele Hammanskraal, Entrance o f Jubilee Hospital Moretele Sr. M. Mosetlha,7172011
44. New Earsterust Clinic NWP-Moretele Stinkwater cluster, next to beer hall Stinkwater Sr.D.K Chabangu
45. Kekanastat/Majaneng CHC NWP-Moretele Temba cluster, next to post office Temba Sr. Maleka, 7100016
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46. Ramotse Clinic NWP-Moretele Temba cluster, next to Primary school Temba Sr.J.Makhetha, 7196073
47. Stinkwater/Refentse CHC NWP-Moretele Stinkwater cluster, next to Fuel Filling station Stinkwater Sr.M.Disemelo, 7155178
48. Suurman Clinic NWP-Moretele Temba cluster, next to Primary school Temba Sr.Ratlabala,0831094893
49. Jubilee Hospital Pharmacy NWP-Moretele Hammanskraal, Entrance of Jubilee Hospital Moretele Mr Peter Dr
50. Temba CHC NWP-Moretele Temba cluster, next to Temba shopping centre Temba Sr.W.Selomo, 7173357
51. Boekenhout Clinic NWP- ODI Block A, Mabopane Mabopane Sr.D.Makhudu, 7021495
52. Odi Hospital Pharmacy NWP- ODI Mabopane, Inside Odi Hospital Odi Mr.A.K.Leballo, 7013460
53. Itireleng Clinic NWP-ODI Zone 2, Ga-Rankuwa Ga-Rankuwa Sr. N.Kwapeng, 7039014/5
54. Kgabo CHC NWP-ODI Wintervelt Wintervelt Sr.M.Loroke, 7040128
55. Mpho ya Batho Clinic NWP-ODI Kromkuil, Wintervelt Wintervelt Sr.M. Ntsie, 0831093212
56. Phedisong 1 Clinic NWP-ODI Zone 1, Ga-Rankuwa Ga-Rankuwa Sr.E.Kawesa, 7033978
57. Phedisong 4 Clinic NWP-ODI Zone 4, Ga-Rankuwa Ga-Rankuwa 012-703 2993
58. Phedisong 6 Clinic NWP-ODI Zone 6, Ga-Rankuwa Ga-Rankuwa 012-703 4700
59. Sedilega Clinic NWP- ODI Block U, Mabopane Mabopane 012-702 2300
60. TIamelong Clinic NWP- ODI Block B, Mabopane Mabopane 012-702 1101
61. Winterveld (Dube) Clinic NWP-ODI Wintervelt 012-704 0135
62. Pabalelo Place o f Safety NWP-ODI Zone 2, Ga-Rankuwa Ga-Rankuwa 012-7031766
CHH = Community Health Centre, Pr. Aut. = Provincial Authority. NWP = North West Province. Blue Font = Belong to Metsweding, Red Font = Sub-depots. Yellow Fill = Not visited
The plan is to spend one day at a clinic and 2 days at Community Health Centre. Preferably, the facilities covered in one week should be equally 
distributed between the Province and the Local Authority. This will facilitate periodical analysis, comparison and reporting.
The following should be available on that day:
• The person in-charge o f the facility.
• The person in-charge of the pharmacy, dispensary and store.
• Records showing daily attendance o f patients and monthly totals since 1st July 2001 to date.
• Stock cards
• Ordering cards or record o f orders made since 1st July 2001 to date.
• Budget and expenditure on medicines and medical supplies for the financial years 2001/02 and 2002/03.
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PRO G RAM M E A T  THE C O M M U N IT Y  H E A LT H  CENTRE
DAY ONE
09 00 hours 
09 15 hours
09 45 hours
10 00 hours 
1130 hours
12 45 hours
13 30 hours
15 00 hours
16 00 hours
Arrival at the Facility
Interview with the Facility Manager.
Introduction to staff.
Sampling o f prescription encounters.
Monitoring Prescription practices/consultation time.
Lunch break.
Monitoring dispensing practices, time and patient knowledge. 
Evaluating Prescribing indicators data.
Leave Facility
DAY TWO
09 00 hours 
09 15 hours
09 45 hours
10 30 hours
12 45 hours
13 30 hours 
15 00 hours
15 30 hours
16 00 hours
Arrival at the Facility.
Interview with in-charge o f pharmacy, dispensary, store. 
Inspection o f physical facilities o f the pharmacy/dispensary/store. 
Examination o f stock cards and stocktaking.
Lunch break.
Examination o f ordering cards/forms/records.
Miscellaneous data collection and observation.
Wrap up.
Leave Facility.
PR O G R AM M E FOR TH E C L IN IC
09 00 hours Arrival at the Facility, and interview with the Facility Manager. 
09 20 hours Introduction to staff.
09 30 hours Sampling and evaluation o f prescription encounters
10 15 hours Monitoring Prescription practices/consultation time
11 00 hours Monitoring dispensing practices, time and patient knowledge
12 30 hours Lunch break.
13 00 hours Inspection o f physical facilities o f the pharmacy/dispensary/store.
15 00 hours Examination o f stock cards, ordering cards and stocktaking
14 30 hours Wrap up
16 00 hours Leave Facility
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